{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:41:28Z","timestamp":1793922088923,"version":"4.8.0"},"reference-count":574,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.phrs.2021.105729","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T01:57:13Z","timestamp":1623376633000},"page":"105729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["The endocannabinoidome in neuropsychiatry: Opportunities and potential risks"],"prefix":"10.1016","volume":"170","author":[{"given":"Gerwyn","family":"Morris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6758-4763","authenticated-orcid":false,"given":"Ken","family":"Walder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6838-4114","authenticated-orcid":false,"given":"Stefan","family":"Kloiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Amminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5554-6946","authenticated-orcid":false,"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara C.","family":"Bortolasci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basant K.","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/19336950.2019.1619436","article-title":"Diverse TRPV1 responses to cannabinoids","volume":"13","author":"Starkus","year":"2019","journal-title":"Channels"},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib2","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O\u2019Sullivan","year":"2016","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.beem.2008.10.013","article-title":"An introduction to the endocannabinoid system: from the early to the latest concepts","volume":"23","author":"De Petrocellis","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB11111 and CB22222","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2020.22.3\/vdimarzo","article-title":"The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders","volume":"22","author":"Di Marzo","year":"2020","journal-title":"Dialogues Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib6","doi-asserted-by":"crossref","first-page":"e00407","DOI":"10.1128\/msystems.00407-19","article-title":"Rapid and concomitant gut microbiota and endocannabinoidome response to diet-induced obesity in mice","volume":"4","author":"Lacroix","year":"2019","journal-title":"mSystems"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"19","key":"10.1016\/j.phrs.2021.105729_bib8","doi-asserted-by":"crossref","first-page":"7026","DOI":"10.3390\/ijms21197026","article-title":"Beyond the canonical endocannabinoid system. a screening of PPAR ligands as FAAH Inhibitors","volume":"21","author":"Brunetti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2021.105729_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","article-title":"Cannabinoid ligands targeting TRP channels","volume":"11","author":"Muller","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13041-017-0318-7","article-title":"The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress","volume":"10","author":"Shi","year":"2017","journal-title":"Mol. Brain"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1073858414524632","article-title":"Endocannabinoids in synaptic plasticity and neuroprotection","volume":"21","author":"Xu","year":"2015","journal-title":"Neuroscientist"},{"issue":"34","key":"10.1016\/j.phrs.2021.105729_bib12","doi-asserted-by":"crossref","first-page":"55840","DOI":"10.18632\/oncotarget.10095","article-title":"Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction","volume":"7","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2016","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.phrs.2021.105729_bib13","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1089\/ars.2012.5100","article-title":"Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate","volume":"19","author":"S\u00e1nchez-Bl\u00e1zquez","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2021.105729_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fnint.2016.00024","article-title":"Endocannabinoids and heterogeneity of glial cells in brain function","volume":"10","author":"Scheller","year":"2016","journal-title":"Front. Integr. Neurosci."},{"issue":"1654","key":"10.1016\/j.phrs.2021.105729_bib15","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0599","article-title":"Astrocytes in endocannabinoid signalling","volume":"369","author":"Navarrete","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib16","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1111\/bph.13106","article-title":"Endocannabinoids modulate human blood-brain barrier permeability in vitro","volume":"172","author":"Hind","year":"2015","journal-title":"Br. J. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/pharmaceutics12030265","article-title":"Cannabinoids, blood-brain barrier, and brain disposition","volume":"12","author":"Calapai","year":"2020","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrn4004","article-title":"Endocannabinoid signalling in reward and addiction","volume":"16","author":"Parsons","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2021.105729_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bcp.2018.09.013","article-title":"Role of the endocannabinoid system in drug addiction","volume":"157","author":"Manzanares","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5152\/eurjrheum.2017.17025","article-title":"The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease","volume":"4","author":"Barrie","year":"2017","journal-title":"Eur. J. Rheumatol."},{"key":"10.1016\/j.phrs.2021.105729_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-662-46450-2_7","article-title":"The role of the endocannabinoid system in pain","volume":"227","author":"Woodhams","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152473","article-title":"Endocannabinoid signaling regulates sleep stability","volume":"11","author":"Pava","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2017.tb00740.x","article-title":"Endocannabinoid signaling and the hypothalamic-pituitary-adrenal axis","volume":"7","author":"Hillard","year":"2016","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.phrs.2021.105729_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.psyneuen.2017.10.015","article-title":"Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress","volume":"87","author":"Surkin","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.phrs.2021.105729_bib25","first-page":"1506","article-title":"The endocannabinoid system: directing eating behavior and macronutrient metabolism","volume":"5","author":"Watkins","year":"2014","journal-title":"Front. Psychol."},{"issue":"29","key":"10.1016\/j.phrs.2021.105729_bib26","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.2174\/1381612820666140130212957","article-title":"Role of the endocannabinoid system in the neuroendocrine responses to inflammation","volume":"20","author":"De Laurentiis","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib27","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/ijms20102516","article-title":"Endocannabinoid system in hepatic glucose metabolism, fatty liver disease, and cirrhosis","volume":"20","author":"Bazwinsky-Wutschke","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.beem.2008.10.012","article-title":"The role of the pancreatic endocannabinoid system in glucose metabolism","volume":"23","author":"Berm\u00fadez-Silva","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.beem.2008.10.002","article-title":"The role of the endocannabinoid system in lipogenesis and fatty acid metabolism","volume":"23","author":"Vettor","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/can.2016.0001","article-title":"Endocannabinoids in the gut","volume":"1","author":"DiPatrizio","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/j.gastro.2016.04.015","article-title":"The role of the endocannabinoid system in the brain-gut axis","volume":"151","author":"Sharkey","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1871529X18666180206161457","article-title":"The endocannabinoid system and heart disease: the role of cannabinoid receptor type 2","volume":"18","author":"Fulmer","year":"2018","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1476-5381.2012.02042.x","article-title":"Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies","volume":"167","author":"Steffens","year":"2012","journal-title":"Br. J. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2174\/1389450115666141202113225","article-title":"The activated endocannabinoid system in atherosclerosis: driving force or protective mechanism?","volume":"16","author":"Steffens","year":"2015","journal-title":"Curr. Drug Targets"},{"issue":"24","key":"10.1016\/j.phrs.2021.105729_bib35","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.3390\/molecules24244626","article-title":"Endocannabinoid system in the airways","volume":"24","author":"Bozkurt","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/can.2018.0060","article-title":"Endocannabinoid system and the kidneys: from renal physiology to injury and disease","volume":"4","author":"Chua","year":"2019","journal-title":"Cannabis Cannabinoid Res."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib37","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tem.2015.07.007","article-title":"The endocannabinoid system: pivotal orchestrator of obesity and metabolic disease","volume":"26","author":"Mazier","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib38","first-page":"171","article-title":"Cannabinoids for treating cardiovascular disorders: putting together a complex puzzle","volume":"6","author":"Eid","year":"2018","journal-title":"J. Microsc. Ultra"},{"key":"10.1016\/j.phrs.2021.105729_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-3-642-17214-4_4","article-title":"Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes","volume":"203","author":"Di Marzo","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib40","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1476-5381.2011.01397.x","article-title":"The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings","volume":"163","author":"Mallat","year":"2011","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib41","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41598-019-38865-4","article-title":"Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer","volume":"9","author":"Grill","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2021.105729_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147135","article-title":"Endocannabinoid system alterations in Alzheimer\u2019s disease: a systematic review of human studies","volume":"1749","author":"Berry","year":"2020","journal-title":"Brain Res."},{"issue":"17","key":"10.1016\/j.phrs.2021.105729_bib43","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.3390\/ijms21176235","article-title":"Distinctive evidence involved in the role of endocannabinoid signalling in Parkinson\u2019s disease: a perspective on associated therapeutic interventions","volume":"21","author":"Behl","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s13167-020-00203-4","article-title":"Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies","volume":"11","author":"Reddy","year":"2020","journal-title":"EPMA J."},{"issue":"21","key":"10.1016\/j.phrs.2021.105729_bib45","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.3390\/molecules25214930","article-title":"A critical review of the role of the cannabinoid compounds \u03949-tetrahydrocannabinol (\u03949-THC) and cannabidiol (CBD) and their combination in multiple sclerosis treatment","volume":"25","author":"Jones","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s40263-018-0539-z","article-title":"Role of the endocannabinoid system in the pathophysiology of schizophrenia: implications for pharmacological intervention","volume":"32","author":"Leweke","year":"2018","journal-title":"CNS Drugs"},{"issue":"235","key":"10.1016\/j.phrs.2021.105729_bib47","first-page":"235","article-title":"Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety-like behavior and sociability","volume":"9","author":"Lutz","year":"2015","journal-title":"Front. Behav. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11920-019-1026-z","article-title":"Cannabinoid regulation of fear and anxiety: an update","volume":"21","author":"Papagianni","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib49","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.3892\/mmr.2016.5585","article-title":"Endocannabinoid system: role in depression, reward and pain control (Review)","volume":"14","author":"Huang","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/mp.2012.33","article-title":"The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications","volume":"18","author":"Moylan","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib51","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib52","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/0004867414533012","article-title":"Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries","volume":"48","author":"Davis","year":"2014","journal-title":"Aust. N.Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41398-020-0832-8","article-title":"Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia","volume":"10","author":"Tao","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41537-020-00110-7","article-title":"Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis","volume":"6","author":"Dickens","year":"2020","journal-title":"NPJ Schizophr."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib55","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.neuroimage.2010.04.034","article-title":"Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR","volume":"52","author":"Wong","year":"2010","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.schres.2014.07.017","article-title":"Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia","volume":"159","author":"Volk","year":"2014","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib57","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.biopsych.2016.04.015","article-title":"Positron emission tomography studies on cannabinoid receptor type 1 in schizophrenia","volume":"79","author":"Mihov","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105729_bib58","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuroimage.2013.04.052","article-title":"Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia","volume":"79","author":"Ceccarini","year":"2013","journal-title":"Neuroimage"},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib59","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jamapsychiatry.2019.1427","article-title":"In vivo availability of cannabinoid 1 receptor levels in patients with first-episode psychosis","volume":"76","author":"Borgan","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib60","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.biopsych.2015.08.021","article-title":"Reduced brain cannabinoid receptor availability in schizophrenia","volume":"79","author":"Ranganathan","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105729_bib61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00406-020-01191-2","article-title":"Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study","volume":"271","author":"Borgan","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.phrs.2021.105729_bib62","series-title":"Vitamins and Hormones","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/bs.vh.2016.09.006","article-title":"Chapter eight - the endocannabinoid system and anxiety","author":"Lisboa","year":"2017"},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib63","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.phrs.2010.01.002","article-title":"Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression","volume":"61","author":"Monteleone","year":"2010","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.psychres.2011.11.021","article-title":"The CNR1 gene in depression and schizophrenia\u2014Is there an association with early improvement and response?","volume":"196","author":"Schennach","year":"2012","journal-title":"Psychiatry Res."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib65","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.euroneuro.2008.05.003","article-title":"Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression","volume":"18","author":"Domschke","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"315","key":"10.1016\/j.phrs.2021.105729_bib66","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fpsyt.2020.00315","article-title":"Endocannabinoid system components as potential biomarkers in psychiatry","volume":"11","author":"Navarrete","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib67","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00702-007-0660-5","article-title":"Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression","volume":"114","author":"Koethe","year":"2007","journal-title":"J. Neural Transm."},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib68","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jpsychires.2012.03.021","article-title":"Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear","volume":"46","author":"Choi","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"46","key":"10.1016\/j.phrs.2021.105729_bib69","doi-asserted-by":"crossref","first-page":"17403","DOI":"10.1097\/MD.0000000000017403","article-title":"The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression: a meta-analysis","volume":"98","author":"Kong","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.phrs.2021.105729_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110096","article-title":"Endocannabinoid system in psychotic and mood disorders, a review of human studies","volume":"106","author":"Garani","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib71","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0269881105051541","article-title":"Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential","volume":"19","author":"Ashton","year":"2005","journal-title":"J. Psychopharmacology"},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib72","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jamapsychiatry.2019.0970","article-title":"Measuring disturbance of the endocannabinoid system in psychosis: a systematic review and meta-analysis","volume":"76","author":"Minichino","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.phrs.2021.105729_bib73","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fpsyt.2020.00628","article-title":"Peripheral endogenous cannabinoid levels are increased in schizophrenia patients evaluated in a psychiatric emergency setting","volume":"11","author":"Potvin","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib74","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.biopsych.2015.12.021","article-title":"Interactions between anandamide and corticotropin-releasing factor signaling modulate human amygdala function and risk for anxiety disorders: an imaging genetics strategy for modeling molecular interactions","volume":"80","author":"Demers","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib75","doi-asserted-by":"crossref","first-page":"62741","DOI":"10.1371\/journal.pone.0062741","article-title":"Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder","volume":"8","author":"Hauer","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-2007-993211","article-title":"Serum Endocannabinoid Content Is Altered In Females With Depressive Disorders: A Preliminary Report","volume":"41","author":"Hill","year":"2008","journal-title":"Pharmacopsychiatry"},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib77","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41398-017-0029-y","article-title":"Schizophrenia and depression, two poles of endocannabinoid system deregulation","volume":"7","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"S1","key":"10.1016\/j.phrs.2021.105729_bib78","doi-asserted-by":"crossref","first-page":"S422","DOI":"10.1016\/j.eurpsy.2016.01.1524","article-title":"Plasma concentrations of endocannabinoids and congeners in a primary care sample of depressed patients: influence of biological variables, severity and antidepressant medication","volume":"33","author":"Romero-Sanchiz","year":"2016","journal-title":"Eur. Psychiatry"},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib79","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1249\/MSS.0000000000002006","article-title":"Serum endocannabinoid and mood changes after exercise in major depressive disorder","volume":"51","author":"Meyer","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib80","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00406-017-0789-7","article-title":"Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study","volume":"267","author":"Kranaster","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib81","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/neu.2019.21","article-title":"Bipolar disorder and the endocannabinoid system","volume":"31","author":"Arjmand","year":"2019","journal-title":"Acta Neuropsychiatr."},{"issue":"16","key":"10.1016\/j.phrs.2021.105729_bib82","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2174\/1568026619666190708164841","article-title":"Overcoming the psychiatric side effects of the cannabinoid CB1 receptor antagonists: current approaches for therapeutics development","volume":"19","author":"Nguyen","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib83","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.beem.2008.09.003","article-title":"Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression","volume":"23","author":"Moreira","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2021.105729_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110163","article-title":"CB1 allosteric modulators and their therapeutic potential in CNS disorders","volume":"106","author":"Mielnik","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"14","key":"10.1016\/j.phrs.2021.105729_bib85","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.3390\/ijms21145064","article-title":"Targeting cannabinoid receptors: current status and prospects of natural products","volume":"21","author":"An","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib86","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/aps.2016.149","article-title":"Brain cannabinoid receptor 2: expression, function and modulation","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2021.105729_bib87","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2019.03.040","article-title":"Mechanisms of cannabinoid CB2 receptor-mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area","volume":"42","author":"Ma","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phrs.2021.105729_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.587154","article-title":"Are CB2 receptors a new target for schizophrenia treatment?","volume":"11","author":"Cortez","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib89","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0269881111400652","article-title":"CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity","volume":"26","author":"Onaivi","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib90","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1196\/annals.1432.036","article-title":"Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression","volume":"1139","author":"Onaivi","year":"2008","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2021.105729_bib91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroscience.2017.08.053","article-title":"Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus","volume":"363","author":"Li","year":"2017","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib92","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.neuron.2016.05.012","article-title":"A central move for CB2 receptors","volume":"90","author":"Quraishi Salma","year":"2016","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib93","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","article-title":"Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus","volume":"90","author":"Stempel","year":"2016","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233020","article-title":"Cannabinoid type 2 receptors inhibit GABAA receptor-mediated currents in cerebellar Purkinje cells of juvenile mice","volume":"15","author":"Sadanandan","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2021.105729_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108538","article-title":"Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice","volume":"189","author":"Zhang","year":"2021","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib96","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neuropharm.2012.04.024","article-title":"CB\u2082 cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons","volume":"63","author":"Atwood","year":"2012","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.phrs.2021.105729_bib97","doi-asserted-by":"crossref","first-page":"22061","DOI":"10.1002\/syn.22061","article-title":"Presynaptic cannabinoid CB2 receptors modulate [3H]-Glutamate release at subthalamo-nigral terminals of the rat","volume":"72","author":"S\u00e1nchez-Zavaleta","year":"2018","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib98","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2017.206","article-title":"CB(1) receptor signaling in the brain: extracting specificity from ubiquity","volume":"43","author":"Busquets-Garcia","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib99","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1113\/jphysiol.2006.115691","article-title":"Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus","volume":"578","author":"Neu","year":"2007","journal-title":"J. Physiol."},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib100","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/npp.2013.157","article-title":"Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotine","volume":"38","author":"Navarrete","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib101","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13311-018-0603-x","article-title":"Cannabinoid CB1 and CB2 receptors, and monoacylglycerol lipase gene expression alterations in the basal ganglia of patients with Parkinson\u2019s disease","volume":"15","author":"Navarrete","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"14","key":"10.1016\/j.phrs.2021.105729_bib102","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1523\/JNEUROSCI.0786-09.2009","article-title":"Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K\/Akt Pathway","volume":"29","author":"Viscomi","year":"2009","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib103","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/ACO.0000000000000616","article-title":"An overview of the cannabinoid type 2 receptor system and its therapeutic potential","volume":"31","author":"Bie","year":"2018","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.phrs.2021.105729_bib104","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/j.pain.0000000000000428","article-title":"The endocannabinoid system and neuropathic pain","volume":"157","author":"Maldonado","year":"2016","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib105","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1523\/JNEUROSCI.1310-16.2016","article-title":"Compensatory activation of cannabinoid CB2 receptor inhibition of GABA release in the rostral ventromedial medulla in inflammatory pain","volume":"37","author":"Li","year":"2017","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib106","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1213\/ANE.0b013e31824b0191","article-title":"Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system","volume":"114","author":"Naguib","year":"2012","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.phrs.2021.105729_bib107","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1744-8069-5-25","article-title":"Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation","volume":"5","author":"Romero-Sandoval","year":"2009","journal-title":"Mol. Pain"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib108","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib109","doi-asserted-by":"crossref","first-page":"10562","DOI":"10.1038\/s41598-018-28763-6","article-title":"CB1 receptor activation induces intracellular Ca2+ mobilization and 2-arachidonoylglycerol release in rodent spinal cord astrocytes","volume":"8","author":"Hegyi","year":"2018","journal-title":"Sci. Rep."},{"issue":"1607","key":"10.1016\/j.phrs.2021.105729_bib110","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1098\/rstb.2011.0387","article-title":"The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling","volume":"367","author":"Reisenberg","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.phrs.2021.105729_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2018.05.002","article-title":"2-Arachidonoylglycerol: a signaling lipid with manifold actions in the brain","volume":"71","author":"Baggelaar","year":"2018","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.phrs.2021.105729_bib112","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuroscience.2010.10.062","article-title":"Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus","volume":"174","author":"Lud\u00e1nyi","year":"2011","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib113","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1124\/mol.107.037796","article-title":"A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization","volume":"72","author":"Jung","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib114","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nn.3353","article-title":"CaMKII regulates diacylglycerol lipase-\u03b1 and striatal endocannabinoid signaling","volume":"16","author":"Shonesy","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib115","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1021\/cr200209p","article-title":"Mechanism of activation and inactivation of Gq\/phospholipase C-\u03b2 signaling nodes","volume":"111","author":"Harden","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.phrs.2021.105729_bib116","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3969023","article-title":"Gq-coupled receptors in autoimmunity","volume":"2016","author":"Zhang","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib117","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/bph.12411","article-title":"Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS","volume":"171","author":"Murataeva","year":"2014","journal-title":"Br. J. Pharm."},{"issue":"37","key":"10.1016\/j.phrs.2021.105729_bib118","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.1523\/JNEUROSCI.2419-04.2004","article-title":"ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase","volume":"24","author":"Walter","year":"2004","journal-title":"J. Neurosci."},{"issue":"23","key":"10.1016\/j.phrs.2021.105729_bib119","doi-asserted-by":"crossref","first-page":"20869","DOI":"10.1074\/jbc.M110813200","article-title":"Astrocytes in culture produce anandamide and other acylethanolamides","volume":"277","author":"Walter","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-2999(01)01182-7","article-title":"Receptor-dependent formation of endogenous cannabinoids in cortical neurons","volume":"425","author":"Stella","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib121","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.neuropharm.2008.01.010","article-title":"Functional lipidomics. Calcium-independent activation of endocannabinoid\/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin","volume":"55","author":"Vellani","year":"2008","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib122","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11745-007-3019-7","article-title":"Bovine brain diacylglycerol lipase: substrate specificity and activation by cyclic AMP-dependent protein kinase","volume":"42","author":"Rosenberger","year":"2007","journal-title":"Lipids"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib123","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0305-0491(97)00280-0","article-title":"Can phosphorylation and dephosphorylation of rod outer segment membranes affect phosphatidate phosphohydrolase and diacylglycerol lipase activities?","volume":"119","author":"P\u00e9rez Roque","year":"1998","journal-title":"Comp. Biochem. Physiol. Part B: Biochem. Mol. Biol."},{"issue":"24","key":"10.1016\/j.phrs.2021.105729_bib124","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1523\/JNEUROSCI.5126-05.2006","article-title":"Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release","volume":"26","author":"Malcher-Lopes","year":"2006","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.phrs.2021.105729_bib125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fcell.2018.00067","article-title":"Neuronal calcium and cAMP cross-talk mediated by cannabinoid CB(1) receptor and EF-hand calcium sensor interactions","volume":"6","author":"Angelats","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib126","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/glia.22623","article-title":"Astrocyte glycogenolysis is triggered by store-operated calcium entry and provides metabolic energy for cellular calcium homeostasis","volume":"62","author":"M\u00fcller","year":"2014","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib127","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ceca.2015.04.004","article-title":"Store-operated Ca2+-entry and adenylyl cyclase","volume":"58","author":"Cooper","year":"2015","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib128","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/ijms12010588","article-title":"Phospholipases A\u2081","volume":"12","author":"Richmond","year":"2011","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib129","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The endocannabinoid system and its modulation by phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib130","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/febs.12152","article-title":"Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways","volume":"280","author":"Ueda","year":"2013","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib131","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1194\/jlr.R057984","article-title":"Phosphoinositide-specific phospholipase C in health and disease","volume":"56","author":"Cocco","year":"2015","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib132","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0003-9861(02)00038-3","article-title":"2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain","volume":"402","author":"Nakane","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib133","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/092986607780090829","article-title":"Critical enzymes involved in endocannabinoid metabolism","volume":"14","author":"Basavarajappa","year":"2007","journal-title":"Protein Pept. Lett."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib134","doi-asserted-by":"crossref","first-page":"16305","DOI":"10.1371\/journal.pone.0016305","article-title":"Endocannabinoids generated by Ca2+ or by metabotropic glutamate receptors appear to arise from different pools of diacylglycerol lipase","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.phrs.2021.105729_bib135","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.2174\/092986710791859414","article-title":"A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling","volume":"17","author":"Labar","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2021.105729_bib136","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.chemphyslip.2015.07.011","article-title":"Monoglyceride lipase: structure and inhibitors","volume":"197","author":"Scalvini","year":"2016","journal-title":"Chem. Phys. Lipids"},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib137","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1476-5381.2011.01486.x","article-title":"COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation","volume":"164","author":"Straiker","year":"2011","journal-title":"Br. J. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib138","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1471-4159.2007.04668.x","article-title":"COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity","volume":"102","author":"Sang","year":"2007","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib139","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/bjp.2008.33","article-title":"Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity","volume":"153","author":"Hu","year":"2008","journal-title":"Br. J. Pharm."},{"issue":"1\u20134","key":"10.1016\/j.phrs.2021.105729_bib140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.prostaglandins.2010.01.003","article-title":"Structural determinants for calcium mobilization by prostaglandin E2 and prostaglandin F2alpha glyceryl esters in RAW 264.7 cells and H1819 cells","volume":"92","author":"Richie-Jannetta","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"47","key":"10.1016\/j.phrs.2021.105729_bib141","doi-asserted-by":"crossref","first-page":"44877","DOI":"10.1074\/jbc.M206788200","article-title":"Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides","volume":"277","author":"Kozak","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib142","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1021\/bi002303b","article-title":"Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase","volume":"40","author":"Moody","year":"2001","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib143","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.200407123","article-title":"A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells","volume":"169","author":"Bektas","year":"2005","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib144","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nchembio.2127","article-title":"A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines","volume":"12","author":"Ogura","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib145","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbalip.2018.02.002","article-title":"Phosphatidylserine-stimulated production of N-acyl-phosphatidylethanolamines by Ca(2+)-dependent N-acyltransferase","volume":"1863","author":"Hussain","year":"2018","journal-title":"Biochim. Et Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.phrs.2021.105729_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0083-6729(09)81001-7","article-title":"Enzymatic formation of anandamide","volume":"81","author":"Okamoto","year":"2009","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.phrs.2021.105729_bib147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.04.001","article-title":"New players in the fatty acyl ethanolamide metabolism","volume":"86","author":"Rahman","year":"2014","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib148","article-title":"Intracellular Ca2+-dependent formation of N-acyl-phosphatidylethanolamines by human cytosolic phospholipase A2\u03b5","volume":"1864","author":"Binte Mustafiz","year":"2019","journal-title":"Biochim. Et Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib149","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/jb\/mvy104","article-title":"The role of intracellular anionic phospholipids in the production of N-acyl-phosphatidylethanolamines by cytosolic phospholipase A2\u025b","volume":"165","author":"Binte Mustafiz","year":"2019","journal-title":"J. Biochem."},{"issue":"11","key":"10.1016\/j.phrs.2021.105729_bib150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113007","article-title":"Characterization of N-acyl phosphatidylethanolamine-specific phospholipase-D isoforms in the nematode caenorhabditis elegans","volume":"9","author":"Harrison","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib151","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq058","article-title":"The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility","volume":"17","author":"Karasu","year":"2011","journal-title":"Hum. Reprod. Update"},{"issue":"18","key":"10.1016\/j.phrs.2021.105729_bib152","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1074\/jbc.M512359200","article-title":"Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-\u03b2-lactamase family","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2021.105729_bib153","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fnmol.2017.00166","article-title":"Metabolism of the endocannabinoid anandamide: open questions after 25 years","volume":"10","author":"Maccarrone","year":"2017","journal-title":"Front Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib154","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1042\/bj20040031","article-title":"Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D","volume":"380","author":"Sun","year":"2004","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib155","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.neuropharm.2008.07.047","article-title":"Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown","volume":"55","author":"Placzek","year":"2008","journal-title":"Neuropharmacology"},{"issue":"36","key":"10.1016\/j.phrs.2021.105729_bib156","doi-asserted-by":"crossref","first-page":"26465","DOI":"10.1074\/jbc.M604660200","article-title":"Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha\/beta-hydrolase 4 in this pathway","volume":"281","author":"Simon","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.phrs.2021.105729_bib157","doi-asserted-by":"crossref","first-page":"13345","DOI":"10.1073\/pnas.0601832103","article-title":"A biosynthetic pathway for anandamide","volume":"103","author":"Liu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"45","key":"10.1016\/j.phrs.2021.105729_bib158","doi-asserted-by":"crossref","first-page":"45034","DOI":"10.1074\/jbc.M306062200","article-title":"Lipopolysaccharide induces anandamide synthesis in macrophages via CD14\/MAPK\/phosphoinositide 3-kinase\/NF-kappaB independently of platelet-activating factor","volume":"278","author":"Liu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2021.105729_bib159","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-319-20825-1_2","article-title":"Biosynthesis and fate of endocannabinoids","volume":"231","author":"Cascio","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"issue":"370","key":"10.1016\/j.phrs.2021.105729_bib160","first-page":"370","article-title":"A personal retrospective: elevating anandamide (AEA) by targeting fatty acid amide hydrolase (FAAH) and the fatty acid binding proteins (FABPs)","volume":"7","author":"Deutsch","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105729_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111953","article-title":"A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents","volume":"188","author":"Tripathi","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib162","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1124\/pr.109.001081","article-title":"Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications","volume":"62","author":"Snider","year":"2010","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib163","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11745-012-3684-z","article-title":"Metabolism of anandamide into eoxamides by 15-lipoxygenase-1 and glutathione transferases","volume":"47","author":"Forsell","year":"2012","journal-title":"Lipids"},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib164","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1021\/cr2002799","article-title":"Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways","volume":"111","author":"Rouzer","year":"2011","journal-title":"Chem. Rev."},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib165","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nn.3480","article-title":"Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation","volume":"16","author":"Hermanson","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib166","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bbalip.2014.12.015","article-title":"Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases","volume":"1851","author":"Urquhart","year":"2015","journal-title":"Biochim. Et Biophys. Acta"},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib167","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2183\/pjab.90.235","article-title":"Control of synaptic function by endocannabinoid-mediated retrograde signaling","volume":"90","author":"Kano","year":"2014","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib168","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pain.2007.04.032","article-title":"The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level","volume":"134","author":"Horvath","year":"2008","journal-title":"PAIN"},{"issue":"1607","key":"10.1016\/j.phrs.2021.105729_bib169","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1098\/rstb.2011.0392","article-title":"Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid\/endovanilloid system","volume":"367","author":"Starowicz","year":"2012","journal-title":"Philos. Trans. R. Soc. B: Biol. Sci."},{"key":"10.1016\/j.phrs.2021.105729_bib170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fnmol.2017.00200","article-title":"Direct anandamide activation of TRPV1 produces divergent calcium and current responses","volume":"10","author":"Fenwick","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib171","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejphar.2012.02.049","article-title":"Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery","volume":"683","author":"Romano","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib172","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s11481-012-9351-6","article-title":"The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55","volume":"7","author":"Sharir","year":"2012","journal-title":"J. Neuroimmune Pharmacol.: Off. J. Soc. Neuroimmune Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib173","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib174","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/1570159X14666160729155441","article-title":"Advances in the physiology of GPR55 in the central nervous system","volume":"15","author":"Marichal-Cancino","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib175","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41232-018-0086-5","article-title":"Endocannabinoids and related N-acylethanolamines: biological activities and metabolism","volume":"38","author":"Tsuboi","year":"2018","journal-title":"Inflamm. Regen."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib176","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"Overton","year":"2006","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib177","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/1440-1681.13238","article-title":"A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-\u03b1, on the management and prevention of obesity","volume":"47","author":"Tutunchi","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib178","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neuropharm.2005.02.013","article-title":"Oleoylethanolamide, an endogenous PPAR-\u03b1 agonist, lowers body weight and hyperlipidemia in obese rats","volume":"48","author":"Fu","year":"2005","journal-title":"Neuropharmacology"},{"issue":"6953","key":"10.1016\/j.phrs.2021.105729_bib179","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha","volume":"425","author":"Fu","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/can.2016.0030","article-title":"Palmitoylethanolamide modulates GPR55 receptor signaling in the ventral hippocampus to regulate mesolimbic dopamine activity, social interaction, and memory processing","volume":"2","author":"Kramar","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.phrs.2021.105729_bib181","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.phrs.2014.05.006","article-title":"Palmitoylethanolamide in CNS health and disease","volume":"86","author":"Mattace Raso","year":"2014","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.phrs.2021.105729_bib182","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/bph.13580","article-title":"The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations","volume":"174","author":"Petrosino","year":"2017","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2021.105729_bib183","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fphar.2019.00430","article-title":"Modulation of the endocannabinoid system as a potential anticancer strategy","volume":"10","author":"Ramer","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib184","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pharmthera.2010.02.004","article-title":"Pharmacological characterization of GPR55, a putative cannabinoid receptor","volume":"126","author":"Sharir","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2021.105729_bib185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/bs.apha.2017.04.004","article-title":"Cannabinoid receptor-related orphan G protein-coupled receptors","volume":"80","author":"Irving","year":"2017","journal-title":"Adv. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib186","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjp.0703050","article-title":"The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)","volume":"129","author":"Smart","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib187","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chemphyslip.2012.06.010","article-title":"Optimized synthesis and characterization of N-acylethanolamines and O-acylethanolamines, important family of lipid-signalling molecules","volume":"165","author":"Ottria","year":"2012","journal-title":"Chem. Phys. Lipids"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib188","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/can.2017.0015","article-title":"N-Arachidonoyl dopamine: a novel endocannabinoid and endovanilloid with widespread physiological and pharmacological activities","volume":"2","author":"Grabiec","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.phrs.2021.105729_bib189","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.plipres.2016.02.002","article-title":"Endocannabinoids and endocannabinoid-related mediators: targets, metabolism and role in neurological disorders","volume":"62","author":"Iannotti","year":"2016","journal-title":"Prog. Lipid Res."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib190","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.301.3.1020","article-title":"Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor","volume":"301","author":"Porter","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib191","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1134\/S1607672917030012","article-title":"N-acyl dopamines induce apoptosis in PC12 cell line via the GPR55 receptor activation","volume":"474","author":"Akimov","year":"2017","journal-title":"Dokl. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib192","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neulet.2005.05.019","article-title":"Fatty acid amidohydrolase in human neocortex\u2014Activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids","volume":"385","author":"Steffens","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib193","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1242\/jcs.065144","article-title":"TRPV1 acts as a synaptic protein and regulates vesicle recycling","volume":"123","author":"Goswami","year":"2010","journal-title":"J. Cell Sci."},{"issue":"350","key":"10.1016\/j.phrs.2021.105729_bib194","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fphar.2019.00350","article-title":"Cannabinoid CB1 and CB2 receptor-mediated arrestin translocation: species, subtype, and agonist-dependence","volume":"10","author":"Ibsen","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib195","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/jnc.14059","article-title":"CB1 receptors down-regulate a cAMP\/Epac2\/PLC pathway to silence the nerve terminals of cerebellar granule cells","volume":"142","author":"Alonso","year":"2017","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib196","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jsb.2013.03.004","article-title":"Interactions of the \u03b1-subunits of heterotrimeric G-proteins with GPCRs, effectors and RGS proteins: a critical review and analysis of interacting surfaces, conformational shifts, structural diversity and electrostatic potentials","volume":"182","author":"Baltoumas","year":"2013","journal-title":"J. Struct. Biol."},{"issue":"89","key":"10.1016\/j.phrs.2021.105729_bib197","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fnagi.2019.00089","article-title":"Gi\/o-protein coupled receptors in the aging brain","volume":"11","author":"de Oliveira","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib198","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.molcel.2014.01.014","article-title":"Double suppression of the G\u03b1 protein activity by RGS proteins","volume":"53","author":"Lin","year":"2014","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib199","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4062\/biomolther.2016.169","article-title":"Recent progress in understanding the conformational mechanism of heterotrimeric G protein activation","volume":"25","author":"Duc","year":"2017","journal-title":"Biomol. Ther."},{"issue":"48","key":"10.1016\/j.phrs.2021.105729_bib200","doi-asserted-by":"crossref","first-page":"E10319","DOI":"10.1073\/pnas.1707992114","article-title":"Specific inhibition of GPCR-independent G protein signaling by a rationally engineered protein","volume":"114","author":"Leyme","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib201","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/bies.201500133","article-title":"Heterotrimeric G protein signaling via GIV\/Girdin: breaking the rules of engagement, space, and time","volume":"38","author":"Aznar","year":"2016","journal-title":"Bioessays"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib202","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/157015906776359586","article-title":"Heterotrimeric g proteins: insights into the neurobiology of mood disorders","volume":"4","author":"Gonz\u00e1lez-Maeso","year":"2006","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib203","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbagen.2013.08.027","article-title":"Structural features of the G-protein\/GPCR interactions","volume":"1840","author":"Moreira","year":"2014","journal-title":"Biochim. Et Biophys. Acta"},{"issue":"14","key":"10.1016\/j.phrs.2021.105729_bib204","first-page":"14","article-title":"Structure, function, pharmacology, and therapeutic potential of the G protein, G\u03b1\/q,11","volume":"2","author":"Kamato","year":"2015","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib205","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s12276-020-0454-5","article-title":"G\u03b112\/13 signaling in metabolic diseases","volume":"52","author":"Yang","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib206","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1021\/acs.jmedchem.9b01452","article-title":"Proteins as therapeutic targets in drug discovery","volume":"63","author":"Li","year":"2020","journal-title":"J. Med. Chem."},{"issue":"B","key":"10.1016\/j.phrs.2021.105729_bib207","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejphar.2015.05.014","article-title":"G\u03b1(i\/o)-coupled receptor-mediated sensitization of adenylyl cyclase: 40 years later","volume":"763","author":"Brust","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib208","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pharmthera.2004.12.005","article-title":"Sensitization of adenylate cyclase by G\u03b1i\/o-coupled receptors","volume":"106","author":"Watts","year":"2005","journal-title":"Pharmacol. Ther."},{"issue":"14","key":"10.1016\/j.phrs.2021.105729_bib209","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2174\/092986710790980023","article-title":"CB(1) cannabinoid receptors and their associated proteins","volume":"17","author":"Howlett","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib210","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1038\/s41467-019-10038-x","article-title":"Structural mechanism underlying G protein family-specific regulation of G protein-gated inwardly rectifying potassium channel","volume":"10","author":"Kano","year":"2019","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.phrs.2021.105729_bib211","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/bph.13866","article-title":"G\u03b1(s) signalling of the CB(1) receptor and the influence of receptor number","volume":"174","author":"Finlay","year":"2017","journal-title":"Br. J. Pharm."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib212","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1080\/15384101.2016.1164371","article-title":"The G protein g\u03b1s acts as a tumor suppressor in sonic hedgehog signaling-driven tumorigenesis","volume":"15","author":"Rao","year":"2016","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib213","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0021-9258(18)46018-8","article-title":"Activation of phospholipase C by the alpha subunits of the Gq and G11 proteins in transfected Cos-7 cells","volume":"267","author":"Wu","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"159","key":"10.1016\/j.phrs.2021.105729_bib214","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1126\/scisignal.2001798","article-title":"Galpha(q) and phospholipase C-beta: turn on, turn off, and do it fast","volume":"4","author":"Ross","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.phrs.2021.105729_bib215","series-title":"Recent Advances in Cannabinoid Research","article-title":"Structural insights from recent CB1 X-ray crystal structures","author":"Al-Zoubi","year":"2019"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib216","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0014-2999(99)00349-0","article-title":"Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor","volume":"374","author":"Calandra","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.phrs.2021.105729_bib217","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gslinkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib218","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1124\/jpet.108.145425","article-title":"Cannabinoid agonists stimulate [3H]GABA release in the globus pallidus of the rat when Gi protein-receptor coupling is restricted: role of dopamine D2 receptors","volume":"328","author":"Gonzalez","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib219","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-2999(01)01438-8","article-title":"Cannabinoid CB1 receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues","volume":"431","author":"Stamer","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000068915","article-title":"The stimulatory effect of cannabinoids on calcium uptake is mediated by Gsssss GTP-binding proteins and cAMP formation","volume":"12","author":"Bash","year":"2003","journal-title":"Neurosignals"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib221","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/can.2016.0037","article-title":"Cannabinoid CB(1) and CB(2) receptor signaling and bias","volume":"2","author":"Ibsen","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.phrs.2021.105729_bib222","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fphar.2016.00415","article-title":"Biased agonism of three different cannabinoid receptor agonists in mouse brain cortex","volume":"7","author":"Diez-Alarcia","year":"2016","journal-title":"Front. Pharm."},{"issue":"52","key":"10.1016\/j.phrs.2021.105729_bib223","doi-asserted-by":"crossref","first-page":"19144","DOI":"10.1073\/pnas.0509588102","article-title":"The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq\/11 G proteins","volume":"102","author":"Lauckner","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib224","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1124\/mol.116.105338","article-title":"G\u03b2\u03b3 pathways in cell polarity and migration linked to oncogenic GPCR signaling: potential relevance in tumor microenvironment","volume":"90","author":"V\u00e1zquez-Prado","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105729_bib225","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.phrs.2016.06.026","article-title":"G\u03b2\u03b3 subunits\u2014Different spaces, different faces","volume":"111","author":"Khan","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib226","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/s41467-018-04432-0","article-title":"Targeting G protein-coupled receptor signaling at the G protein level with a selective nanobody inhibitor","volume":"9","author":"Gulati","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2021.105729_bib227","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.physiol.69.022405.154712","article-title":"Regulation of receptor trafficking by GRKs and arrestins","volume":"69","author":"Moore","year":"2007","journal-title":"Annu. Rev. Physiol."},{"issue":"7447","key":"10.1016\/j.phrs.2021.105729_bib228","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nature12120","article-title":"Structure of active \u03b2-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide","volume":"497","author":"Shukla","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib229","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2017.07.002","article-title":"Identification of phosphorylation codes for arrestin recruitment by G protein-coupled receptors","volume":"170","author":"Zhou","year":"2017","journal-title":"Cell"},{"issue":"185","key":"10.1016\/j.phrs.2021.105729_bib230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1126\/scisignal.2001707","article-title":"Distinct phosphorylation sites on the \u03b2(2)-adrenergic receptor establish a barcode that encodes differential functions of \u03b2-arrestin","volume":"4","author":"Nobles","year":"2011","journal-title":"Sci. Signal."},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib231","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1124\/mol.115.103176","article-title":"Mechanisms of biased \u03b2-arrestin-mediated signaling downstream from the cannabinoid 1 receptor","volume":"89","author":"Delgado-Peraza","year":"2016","journal-title":"Mol. Pharmacol."},{"issue":"125","key":"10.1016\/j.phrs.2021.105729_bib232","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fphar.2019.00125","article-title":"GPCR signaling regulation: the role of GRKs and arrestins","volume":"10","author":"Gurevich","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib233","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/gene.2015.26","article-title":"G-protein-coupled receptor kinases in inflammation and disease","volume":"16","author":"Packiriswamy","year":"2015","journal-title":"Genes Immun."},{"issue":"7562","key":"10.1016\/j.phrs.2021.105729_bib234","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature14656","article-title":"Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser","volume":"523","author":"Kang","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib235","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuropharm.2007.06.005","article-title":"Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1\/2 MAP kinase signaling","volume":"54","author":"Daigle","year":"2008","journal-title":"Neuropharmacology"},{"issue":"7513","key":"10.1016\/j.phrs.2021.105729_bib236","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nature13430","article-title":"Visualization of arrestin recruitment by a G-protein-coupled receptor","volume":"512","author":"Shukla","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib237","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/mol.116.104539","article-title":"The multiple waves of cannabinoid 1 receptor signaling","volume":"90","author":"Nogueras-Ortiz","year":"2016","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib238","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"14","key":"10.1016\/j.phrs.2021.105729_bib239","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1074\/jbc.M112.438804","article-title":"Distinct roles of \u03b2-arrestin 1 and \u03b2-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1)","volume":"288","author":"Ahn","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.phrs.2021.105729_bib240","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tem.2015.09.001","article-title":"Emerging functional divergence of \u03b2-arrestin isoforms in GPCR function","volume":"26","author":"Srivastava","year":"2015","journal-title":"Trends Endocrinol. Metab.: TEM"},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib241","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tem.2006.03.008","article-title":"GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling","volume":"17","author":"Reiter","year":"2006","journal-title":"Trends Endocrinol. Metab.: TEM"},{"issue":"17","key":"10.1016\/j.phrs.2021.105729_bib242","doi-asserted-by":"crossref","first-page":"8969","DOI":"10.1074\/jbc.R115.713313","article-title":"The \u03b2-arrestins: multifunctional regulators of G protein-coupled receptors","volume":"291","author":"Smith","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2021.105729_bib243","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/B978-0-12-394440-5.00005-X","article-title":"Arrestins as regulators of kinases and phosphatases","volume":"118","author":"Luttrell","year":"2013","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib244","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/mol.116.103465","article-title":"Antagonism of dopamine receptor 2 long affects cannabinoid receptor 1 signaling in a cell culture model of striatal medium spiny projection neurons","volume":"89","author":"Bagher","year":"2016","journal-title":"Mol. Pharmacol."},{"issue":"20","key":"10.1016\/j.phrs.2021.105729_bib245","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.3390\/ijms21207693","article-title":"Cannabinoid receptors: an update on cell signaling, pathophysiological roles and therapeutic opportunities in neurological, cardiovascular, and inflammatory diseases","volume":"21","author":"Haspula","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib246","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00109-011-0824-5","article-title":"Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system","volume":"90","author":"Lazzerini","year":"2011","journal-title":"J. Mol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib247","doi-asserted-by":"crossref","first-page":"29239","DOI":"10.1371\/journal.pone.0029239","article-title":"Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons","volume":"7","author":"Rozenfeld","year":"2012","journal-title":"PLoS One"},{"issue":"43","key":"10.1016\/j.phrs.2021.105729_bib248","doi-asserted-by":"crossref","first-page":"37414","DOI":"10.1074\/jbc.M111.287649","article-title":"Heteromultimerization of Cannabinoid CB1receptor and orexin OX1receptor generates a unique complex in which both protomers are regulated by orexin A","volume":"286","author":"Ward","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2021.105729_bib249","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ebiom.2017.01.003","article-title":"Targeting cutaneous cannabinoid signaling in inflammation - a \u201chigh\u201d-way to heal?","volume":"16","author":"Ol\u00e1h","year":"2017","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib250","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41589-019-0387-2","article-title":"Structure of an allosteric modulator bound to the CB1 cannabinoid receptor","volume":"15","author":"Shao","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib251","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/acschemneuro.6b00310","article-title":"Enantiospecific allosteric modulation of cannabinoid 1 receptor","volume":"8","author":"Laprairie","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"54","key":"10.1016\/j.phrs.2021.105729_bib252","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fnmol.2020.00054","article-title":"Positive allosteric modulation of CB1 cannabinoid receptor signaling enhances morphine antinociception and attenuates morphine tolerance without enhancing morphine- induced dependence or reward","volume":"13","author":"Slivicki","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib253","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2021.105729_bib254","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","volume":"168","author":"Mackie","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"issue":"294","key":"10.1016\/j.phrs.2021.105729_bib255","first-page":"294","article-title":"Cannabinoid receptors in the central nervous system: their signaling and roles in disease","volume":"10","author":"Kendall","year":"2016","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib256","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib257","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00429-012-0425-2","article-title":"Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons","volume":"218","author":"Veress","year":"2013","journal-title":"Brain Struct. Funct."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib258","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nn.2632","article-title":"Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism","volume":"13","author":"Clapper","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib259","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1096\/fj.06-7957com","article-title":"The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling","volume":"22","author":"Tam","year":"2007","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib260","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/ejn.14407","article-title":"Modulatory effects of cannabinoids on brain neurotransmission","volume":"50","author":"Cohen","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2021.105729_bib261","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuropharm.2017.04.033","article-title":"Endocannabinoid modulation of dopamine neurotransmission","volume":"124","author":"Covey","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib262","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.phrs.2021.105729_bib263","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","article-title":"Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons","volume":"19","author":"Katona","year":"1999","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib264","first-page":"257","article-title":"Mechanisms of long-term plasticity of hippocampal GABAergic synapses","volume":"82","author":"Rozov","year":"2017","journal-title":"Biochemistry"},{"issue":"51","key":"10.1016\/j.phrs.2021.105729_bib265","doi-asserted-by":"crossref","first-page":"18333","DOI":"10.1073\/pnas.1420285111","article-title":"Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training","volume":"111","author":"Morena","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib266","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1152\/jn.00266.2009","article-title":"Cannabinoid CB1 receptor-dependent long-term depression in autaptic excitatory neurons","volume":"102","author":"Kellogg","year":"2009","journal-title":"J. Neurophysiol."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib267","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1007\/s12035-016-0313-5","article-title":"Endocannabinoid system: the direct and indirect involvement in the memory and learning processes-a short review","volume":"54","author":"Kruk-Slomka","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"45","key":"10.1016\/j.phrs.2021.105729_bib268","doi-asserted-by":"crossref","first-page":"10792","DOI":"10.1523\/JNEUROSCI.1824-17.2017","article-title":"Emerging mechanisms underlying dynamics of GABAergic synapses","volume":"37","author":"Maffei","year":"2017","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib269","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13041-017-0306-y","article-title":"The role of 5-HT receptors in depression","volume":"10","author":"Yohn","year":"2017","journal-title":"Mol. Brain"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib270","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1471-4159.2009.06025.x","article-title":"Lack of CB1 receptor activity impairs serotonergic negative feedback","volume":"109","author":"Aso","year":"2009","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib271","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/npp.2017.126","article-title":"Endocannabinoid regulation of reward and reinforcement through interaction with dopamine and endogenous opioid signaling","volume":"43","author":"Wenzel","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2021.105729_bib272","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnint.2013.00093","article-title":"Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of lister hooded rats","volume":"7","author":"Melis","year":"2013","journal-title":"Front. Integr. Neurosci."},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib273","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.celrep.2015.08.041","article-title":"Cocaine-induced endocannabinoid mobilization in the ventral tegmental area","volume":"12","author":"Wang","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2021.105729_bib274","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fnbeh.2011.00067","article-title":"Cannabinoid CB1 and dopamine D1 receptors partnership in the modulation of emotional neural processing","volume":"5","author":"Akirav","year":"2011","journal-title":"Front. Behav. Neurosci."},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib275","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/bph.13226","article-title":"Role of the endocannabinoid system in diabetes and diabetic complications","volume":"173","author":"Gruden","year":"2016","journal-title":"Br. J. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib276","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/bjp.2008.130","article-title":"The endocannabinoid system in brain reward processes","volume":"154","author":"Solinas","year":"2008","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib277","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1038\/ijosup.2014.8","article-title":"New horizons on the role of cannabinoid CB1 receptors in palatable food intake, obesity and related dysmetabolism","volume":"4","author":"Cristino","year":"2014","journal-title":"Int J. Obes. Suppl."},{"key":"10.1016\/j.phrs.2021.105729_bib278","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fnins.2018.00271","article-title":"Hedonic eating and the \u201cdelicious circle\u201d: from lipid-derived mediators to brain dopamine and back","volume":"12","author":"Coccurello","year":"2018","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib279","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1369-1600.2008.00113.x","article-title":"Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies","volume":"13","author":"Le Foll","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.phrs.2021.105729_bib280","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005353.pub3","article-title":"Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation","volume":"4","author":"Cahill","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2021.105729_bib281","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuroscience.2013.05.035","article-title":"Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents","volume":"247","author":"\u00c1lvaro-Bartolom\u00e9","year":"2013","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib282","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/mp.2012.100","article-title":"Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography","volume":"18","author":"Hirvonen","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib283","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-244X-11-25","article-title":"Comorbid mental disorders in substance users from a single catchment area - a clinical study","volume":"11","author":"Lang\u00e5s","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.phrs.2021.105729_bib284","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.neubiorev.2019.09.025","article-title":"Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders","volume":"107","author":"Morris","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib285","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(97)89683-5","article-title":"Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A","volume":"327","author":"Gessa","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib286","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1101\/lm.1893710","article-title":"Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat","volume":"17","author":"Goonawardena","year":"2010","journal-title":"Learn. Mem."},{"issue":"35","key":"10.1016\/j.phrs.2021.105729_bib287","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1073\/pnas.1525066113","article-title":"Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation","volume":"113","author":"Busquets-Garcia","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib288","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.neuropharm.2012.06.003","article-title":"Presynaptic \u03b1\u2082-adrenoceptors control the inhibitory action of presynaptic CB\u2081 cannabinoid receptors on prefrontocortical norepinephrine release in the rat","volume":"63","author":"Richter","year":"2012","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib289","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/10253890.2011.586753","article-title":"Endocannabinoids and stress","volume":"14","author":"Riebe","year":"2011","journal-title":"Stress"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib290","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.neubiorev.2013.08.002","article-title":"Cannabinoids and glucocorticoids modulate emotional memory after stress","volume":"37","author":"Akirav","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2021.105729_bib291","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/ijnp\/pyaa008","article-title":"Induced ketosis as a treatment for neuroprogressive disorders: food for thought?","volume":"23","author":"Morris","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2021.105729_bib292","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109858","article-title":"The role of microglia in neuroprogressive disorders: mechanisms and possible neurotherapeutic effects of induced ketosis","volume":"99","author":"Morris","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105729_bib293","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12974-015-0463-9","article-title":"Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines","volume":"13","author":"Ghosh","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2021.105729_bib294","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbr.2017.12.036","article-title":"Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases","volume":"341","author":"Morris","year":"2018","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib295","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1007\/s12035-016-0004-2","article-title":"The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease","volume":"54","author":"Morris","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib296","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s12035-015-9090-9","article-title":"The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases","volume":"53","author":"Morris","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib297","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1192\/j.eurpsy.2019.13","article-title":"Nutritional ketosis as an intervention to relieve astrogliosis: possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders","volume":"63","author":"Morris","year":"2020","journal-title":"Eur. Psychiatry.: J. Assoc. Eur. Psychiatr."},{"issue":"45","key":"10.1016\/j.phrs.2021.105729_bib298","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fnsyn.2018.00045","article-title":"Astrocyte-neuron networks: a multilane highway of signaling for homeostatic brain function","volume":"10","author":"Mederos","year":"2018","journal-title":"Front. Synaptic Neurosci."},{"issue":"1114","key":"10.1016\/j.phrs.2021.105729_bib299","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3389\/fphar.2019.01114","article-title":"Astrocytes: role and functions in brain pathologies","volume":"10","author":"Siracusa","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105729_bib300","article-title":"Astrocytes phagocytose adult hippocampal synapses for circuit homeostasis","author":"Lee","year":"2020","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.phrs.2021.105729_bib301","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.3390\/ijms21228653","article-title":"The anti-neuroinflammatory role of anthocyanins and their metabolites for the prevention and treatment of brain disorders","volume":"21","author":"Henriques","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2021.105729_bib302","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fncel.2019.00514","article-title":"Pharmacological targeting of microglial activation: new therapeutic approach","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"5642","key":"10.1016\/j.phrs.2021.105729_bib303","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib304","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/npp.2010.214","article-title":"Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation","volume":"36","author":"Zoppi","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib305","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/cdd.2015.11","article-title":"The CB\u2081 cannabinoid receptor signals striatal neuroprotection via a PI3K\/Akt\/mTORC1\/BDNF pathway","volume":"22","author":"Bl\u00e1zquez","year":"2015","journal-title":"Cell Death Differ."},{"issue":"22","key":"10.1016\/j.phrs.2021.105729_bib306","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1073\/pnas.1400988111","article-title":"A restricted population of CB1 cannabinoid receptors with neuroprotective activity","volume":"111","author":"Chiarlone","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib307","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.0022-3042.2001.00716.x","article-title":"Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1","volume":"80","author":"Marsicano","year":"2002","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib308","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1124\/jpet.114.216598","article-title":"Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase","volume":"351","author":"McDougle","year":"2014","journal-title":"J. Pharm. Exp. Ther."},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib309","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Liu Q-s, Lichtman AH, Cravatt BF. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2021.105729_bib310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2014.03.017","article-title":"Endocannabinoid-mediated retrograde modulation of synaptic transmission","volume":"29","author":"Ohno-Shosaku","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"issue":"182","key":"10.1016\/j.phrs.2021.105729_bib311","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fncel.2018.00182","article-title":"Endocannabinoid-LTP mediated by CB1 and TRPV1 receptors encodes for limited occurrences of coincident activity in neocortex","volume":"12","author":"Cui","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib312","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm.f.1869","article-title":"Endocannabinoid signaling as a synaptic circuit breaker in neurological disease","volume":"14","author":"Katona","year":"2008","journal-title":"Nat. Med."},{"issue":"31","key":"10.1016\/j.phrs.2021.105729_bib313","doi-asserted-by":"crossref","first-page":"12627","DOI":"10.1523\/JNEUROSCI.1028-13.2013","article-title":"Anandamide, cannabinoid type 1 receptor, and NMDA receptor activation mediate non-Hebbian presynaptically expressed long-term depression at the first central synapse for visceral afferent fibers","volume":"33","author":"Khlaifia","year":"2013","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib314","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/nn.2684","article-title":"TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus","volume":"13","author":"Ch\u00e1vez","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib315","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/nn.2685","article-title":"Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens","volume":"13","author":"Grueter","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib316","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nn2042","article-title":"Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum","volume":"11","author":"Maccarrone","year":"2008","journal-title":"Nat. Neurosci."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib317","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/0004867418796955","article-title":"Leaky brain in neurological and psychiatric disorders: drivers and consequences","volume":"52","author":"Morris","year":"2018","journal-title":"Aust. N.Z. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib318","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2008.01.029","article-title":"Endocannabinoids mediate neuron-astrocyte communication","volume":"57","author":"Navarrete","year":"2008","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib319","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1460-9568.2009.06816.x","article-title":"Neuronal and glial localization of the cannabinoid-1 receptor in the superficial spinal dorsal horn of the rodent spinal cord","volume":"30","author":"Hegyi","year":"2009","journal-title":"Eur. J. Neurosci."},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib320","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.20983","article-title":"Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas","volume":"58","author":"Stella","year":"2010","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib321","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuron.2005.11.027","article-title":"The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells","volume":"49","author":"Eljaschewitsch","year":"2006","journal-title":"Neuron"},{"issue":"22","key":"10.1016\/j.phrs.2021.105729_bib322","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1523\/JNEUROSCI.22-22-09742.2002","article-title":"Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase\/Akt signaling","volume":"22","author":"Molina-Holgado","year":"2002","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib323","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s12017-014-8314-x","article-title":"Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier","volume":"16","author":"Vendel","year":"2014","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.phrs.2021.105729_bib324","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bcp.2019.07.017","article-title":"Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB(1), TRPV1, and PPAR\u03b1","volume":"168","author":"Karwad","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105729_bib325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuropharm.2017.06.017","article-title":"Synaptic functions of endocannabinoid signaling in health and disease","volume":"124","author":"Araque","year":"2017","journal-title":"Neuropharmacology"},{"issue":"21","key":"10.1016\/j.phrs.2021.105729_bib326","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1523\/JNEUROSCI.1054-12.2012","article-title":"Bimodal control of fear-coping strategies by CB1 cannabinoid receptors","volume":"32","author":"Metna-Laurent","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2021.105729_bib327","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuroscience.2015.05.002","article-title":"Astroglial type-1 cannabinoid receptor (CB1): a new player in the tripartite synapse","volume":"323","author":"Oliveira da Cruz","year":"2016","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib328","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/glia.22773","article-title":"Rising stars: modulation of brain functions by astroglial type-1 cannabinoid receptors","volume":"63","author":"Metna-Laurent","year":"2015","journal-title":"Glia"},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib329","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/cercor\/bhu231","article-title":"Endocannabinoids induce lateral long-term potentiation of transmitter release by stimulation of gliotransmission","volume":"25","author":"G\u00f3mez-Gonzalo","year":"2015","journal-title":"Cereb. Cortex"},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib330","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.neuron.2018.04.034","article-title":"Astroglial CB1 receptors determine synaptic D-serine availability to enable recognition memory","volume":"98","author":"Robin","year":"2018","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib331","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11064-019-02834-0","article-title":"Astrocytic endocannabinoids mediate hippocampal transient heterosynaptic depression","volume":"45","author":"Smith","year":"2020","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib332","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuron.2010.08.043","article-title":"Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes","volume":"68","author":"Navarrete","year":"2010","journal-title":"Neuron"},{"issue":"41","key":"10.1016\/j.phrs.2021.105729_bib333","doi-asserted-by":"crossref","first-page":"20736","DOI":"10.1073\/pnas.1909458116","article-title":"The NMDA receptor activation by d-serine and glycine is controlled by an astrocytic Phgdh-dependent serine shuttle","volume":"116","author":"Neame","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"544","key":"10.1016\/j.phrs.2021.105729_bib334","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fpsyt.2018.00544","article-title":"Astrocytic regulation of glutamate transmission in schizophrenia","volume":"9","author":"Mei","year":"2018","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib335","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cell.2012.01.037","article-title":"Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD","volume":"148","author":"Han","year":"2012","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib336","doi-asserted-by":"crossref","first-page":"37320","DOI":"10.1371\/journal.pone.0037320","article-title":"Neuron to astrocyte communication via cannabinoid receptors is necessary for sustained epileptiform activity in rat hippocampus","volume":"7","author":"Coiret","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib337","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1124\/mol.63.4.908","article-title":"The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa\/fa rats and in cultured adipocyte cells","volume":"63","author":"Bensaid","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"38","key":"10.1016\/j.phrs.2021.105729_bib338","doi-asserted-by":"crossref","first-page":"14561","DOI":"10.1073\/pnas.0807232105","article-title":"Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins","volume":"105","author":"Ruby","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib339","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1172\/JCI34827","article-title":"Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice","volume":"118","author":"Osei-Hyiaman","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib340","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12916-020-01749-w","article-title":"Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments","volume":"18","author":"Morris","year":"2020","journal-title":"BMC Med."},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib341","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S2215-0366(19)30132-4","article-title":"The lancet psychiatry commission: a blueprint for protecting physical health in people with mental illness","volume":"6","author":"Firth","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib342","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/wps.20420","article-title":"Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls","volume":"16","author":"Correll","year":"2017","journal-title":"World Psychiatry.: Off. J. World Psychiatr. Assoc."},{"key":"10.1016\/j.phrs.2021.105729_bib343","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pnpbp.2017.04.027","article-title":"Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders","volume":"78","author":"de Melo","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib344","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.bjp.0707582","article-title":"Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning","volume":"153","author":"Pacher","year":"2008","journal-title":"Br. J. Pharm."},{"issue":"11","key":"10.1016\/j.phrs.2021.105729_bib345","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1172\/JCI83626","article-title":"Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages","volume":"127","author":"Ruiz de Azua","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib346","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1476-5381.2011.01352.x","article-title":"The case for peripheral CB1receptor blockade in the treatment of visceral obesity and its cardiometabolic complications","volume":"163","author":"Kunos","year":"2011","journal-title":"Br. J. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib347","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cmet.2013.03.001","article-title":"The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders","volume":"17","author":"Silvestri","year":"2013","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib348","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1096\/fj.13-247643","article-title":"Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity","volume":"28","author":"Boon","year":"2014","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib349","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.gastro.2012.01.032","article-title":"Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice","volume":"142","author":"Liu","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib350","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.26606","article-title":"Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasingde novosynthesis of long-chain ceramides","volume":"59","author":"Cinar","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib351","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s00125-018-4576-4","article-title":"Absence of cannabinoid 1 receptor in beta cells protects against high-fat\/high-sugar diet-induced beta cell dysfunction and inflammation in murine islets","volume":"61","author":"Gonz\u00e1lez-Mariscal","year":"2018","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib352","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1111\/jcmm.13523","article-title":"Blockade of cannabinoid 1 receptor improves glucose responsiveness in pancreatic beta cells","volume":"22","author":"Shin","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"14","key":"10.1016\/j.phrs.2021.105729_bib353","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009099","article-title":"Cannabinoids, the heart of the matter","volume":"7","author":"Alfulaij","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib354","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2337\/db11-0477","article-title":"Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy","volume":"61","author":"Rajesh","year":"2012","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib355","doi-asserted-by":"crossref","first-page":"15645","DOI":"10.1038\/s41598-017-15154-6","article-title":"Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity","volume":"7","author":"Mehrpouya-Bahrami","year":"2017","journal-title":"Sci. Rep."},{"issue":"40","key":"10.1016\/j.phrs.2021.105729_bib356","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.2174\/1381612822666160914182822","article-title":"The role of microbiota and intestinal permeability in the pathophysiology of autoimmune and neuroimmune processes with an emphasis on inflammatory bowel disease type 1 diabetes and chronic fatigue syndrome","volume":"22","author":"Morris","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib357","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000448957","article-title":"Gut microbiota, bacterial translocation, and interactions with diet: pathophysiological links between major depressive disorder and non-communicable medical comorbidities","volume":"86","author":"Slyepchenko","year":"2017","journal-title":"Psychother. Psychosom."},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib358","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gut.48.6.859","article-title":"Cannabinoids and the gastrointestinal tract","volume":"48","author":"Pertwee","year":"2001","journal-title":"Gut"},{"issue":"704","key":"10.1016\/j.phrs.2021.105729_bib359","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3389\/fphys.2019.00704","article-title":"Cannabinoid CB1 receptors inhibit gut-brain satiation signaling in diet-induced obesity","volume":"10","author":"Argueta","year":"2019","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib360","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1096\/fj.201601346R","article-title":"The role of CB(1) in intestinal permeability and inflammation","volume":"31","author":"Karwad","year":"2017","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib361","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0026-895X(25)10252-6","article-title":"Characterization of drug resistance mediated via the suppression of apoptosis by Abelson protein tyrosine kinase","volume":"48","author":"Chapman","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib362","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1476-5381.2011.01673.x","article-title":"Cannabinoid CB(2) receptors modulate ERK-1\/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide","volume":"165","author":"Merighi","year":"2012","journal-title":"Br. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105729_bib363","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-5793(95)01207-U","article-title":"The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling","volume":"375","author":"Bayewitch","year":"1995","journal-title":"FEBS Lett."},{"issue":"2\u20133","key":"10.1016\/j.phrs.2021.105729_bib364","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0014-5793(00)01094-2","article-title":"Role of the highly conserved Asp-Arg-Tyr motif in signal transduction of the CB2 cannabinoid receptor","volume":"466","author":"Rhee","year":"2000","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib365","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.4049\/jimmunol.177.8.4971","article-title":"Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells","volume":"177","author":"Bari","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib366","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1038\/ncomms13958","article-title":"Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity","volume":"8","author":"Soethoudt","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib367","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1124\/jpet.105.089474","article-title":"Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors","volume":"315","author":"Shoemaker","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib368","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bjp.0706215","article-title":"Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1\/2 kinase signaling","volume":"145","author":"Correa","year":"2005","journal-title":"Br. J. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib369","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ajpath.2012.11.024","article-title":"Activation of cannabinoid CB2 receptor\u2013mediated AMPK\/CREB pathway reduces cerebral ischemic injury","volume":"182","author":"Choi","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib370","doi-asserted-by":"crossref","first-page":"63262","DOI":"10.1371\/journal.pone.0063262","article-title":"The second intracellular loop of the human cannabinoid CB2 receptor governs G protein coupling in coordination with the carboxyl terminal domain","volume":"8","author":"Zheng","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib371","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/acsptsci.9b00049","article-title":"Cannabinoid receptor 2 (CB2) signals via G-alpha-s and induces IL-6 and IL-10 cytokine secretion in human primary leukocytes","volume":"2","author":"Saroz","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"30","key":"10.1016\/j.phrs.2021.105729_bib372","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1021\/bi500632a","article-title":"Differential activation of intracellular versus plasmalemmal CB2 cannabinoid receptors","volume":"53","author":"Brailoiu","year":"2014","journal-title":"Biochemistry"},{"issue":"26","key":"10.1016\/j.phrs.2021.105729_bib373","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","article-title":"Beta-caryophyllene is a dietary cannabinoid","volume":"105","author":"Gertsch","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"51","key":"10.1016\/j.phrs.2021.105729_bib374","doi-asserted-by":"crossref","first-page":"35450","DOI":"10.1074\/jbc.M109.006338","article-title":"Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling","volume":"284","author":"B\u00f6rner","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2021.105729_bib375","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-2-29","article-title":"Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation","volume":"2","author":"Ehrhart","year":"2005","journal-title":"J. Neuroinflamm."},{"issue":"22","key":"10.1016\/j.phrs.2021.105729_bib376","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1016\/j.febslet.2005.08.021","article-title":"p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells","volume":"579","author":"Herrera","year":"2005","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.phrs.2021.105729_bib377","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.yexcr.2006.03.009","article-title":"The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway","volume":"312","author":"Herrera","year":"2006","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib378","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/mol.111.074013","article-title":"Functional selectivity in CB22222 cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB22222 ligands","volume":"81","author":"Atwood","year":"2012","journal-title":"Mol. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib379","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.bbamcr.2011.05.010","article-title":"Cannabinoid receptor 2 undergoes Rab5-mediated internalization and recycles via a Rab11-dependent pathway","volume":"1813","author":"Grimsey","year":"2011","journal-title":"Biochim. Et Biophys. Acta (BBA) - Mol. Cell Res."},{"key":"10.1016\/j.phrs.2021.105729_bib380","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.ejmech.2013.09.038","article-title":"Mastering tricyclic ring systems for desirable functional cannabinoid activity","volume":"69","author":"Petrov","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib381","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1087057108327329","article-title":"Characterizing cannabinoid CB2 receptor ligands using DiscoveRx pathhunter beta-arrestin assay","volume":"14","author":"McGuinness","year":"2009","journal-title":"J. Biomol. Screen."},{"issue":"1202","key":"10.1016\/j.phrs.2021.105729_bib382","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3389\/fphar.2018.01202","article-title":"Cannabinoid receptor 2 signalling bias elicited by 2,4,6-trisubstituted 1,3,5-triazines","volume":"9","author":"Oyagawa","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"24","key":"10.1016\/j.phrs.2021.105729_bib383","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1091\/mbc.e17-03-0198","article-title":"Retromer stops beta-arrestin 1-mediated signaling from internalized cannabinoid 2 receptors","volume":"28","author":"Nogueras-Ortiz","year":"2017","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib384","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/jpet.116.232561","article-title":"Functional selectivity of CB2 cannabinoid receptor ligands at a canonical and noncanonical pathway","volume":"358","author":"Dhopeshwarkar","year":"2016","journal-title":"J. Pharm. Exp. Ther."},{"issue":"19","key":"10.1016\/j.phrs.2021.105729_bib385","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1074\/jbc.M115.712661","article-title":"Simultaneous activation of induced heterodimerization between CXCR4 chemokine receptor and cannabinoid receptor 2 (CB2) reveals a mechanism for regulation of tumor progression","volume":"291","author":"Coke","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib386","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/jpet.107.135053","article-title":"First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain","volume":"325","author":"Benamar","year":"2008","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.phrs.2021.105729_bib387","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fphar.2019.00339","article-title":"The endocannabinoid system as a target in cancer diseases: are we there yet?","volume":"10","author":"Moreno","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib388","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib389","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","article-title":"Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain","volume":"1074","author":"Onaivi","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib390","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000100778","article-title":"Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain","volume":"54","author":"Onaivi","year":"2006","journal-title":"Neuropsychobiology"},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib391","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1476-5381.2010.00819.x","article-title":"Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors","volume":"160","author":"Garc\u00eda-Guti\u00e9rrez","year":"2010","journal-title":"Br. J. Pharm."},{"issue":"46","key":"10.1016\/j.phrs.2021.105729_bib392","doi-asserted-by":"crossref","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","article-title":"Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib393","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.bjp.0707584","article-title":"CB2 receptors in the brain: role in central immune function","volume":"153","author":"Cabral","year":"2008","journal-title":"Br. J. Pharm."},{"issue":"30","key":"10.1016\/j.phrs.2021.105729_bib394","first-page":"30","article-title":"Cannabinoid receptor 2 signaling in neurodegenerative disorders: from pathogenesis to a promising therapeutic target","volume":"11","author":"Cassano","year":"2017","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib395","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s13311-018-0610-y","article-title":"Alterations in gene and protein expression of cannabinoid CB2 and GPR55 receptors in the dorsolateral prefrontal cortex of suicide victims","volume":"15","author":"Garc\u00eda-Guti\u00e9rrez","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib396","doi-asserted-by":"crossref","first-page":"17410","DOI":"10.1038\/s41598-017-17796-y","article-title":"Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2021.105729_bib397","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/bs.apha.2017.03.009","article-title":"Is the cannabinoid CB(2) receptor a major regulator of the neuroinflammatory axis of the neurovascular unit in humans?","volume":"80","author":"Kho","year":"2017","journal-title":"Adv. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib398","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.3390\/ijms15058063","article-title":"CB2 receptor activation inhibits melanoma cell transmigration through the blood-brain barrier","volume":"15","author":"Hask\u00f3","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2021.105729_bib399","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2019.03.040","article-title":"Mechanisms of cannabinoid CB(2) receptor-mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area","volume":"42","author":"Ma","year":"2019","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.phrs.2021.105729_bib400","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1111\/bph.12607","article-title":"Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice","volume":"171","author":"Zoppi","year":"2014","journal-title":"Br. J. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib401","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/WNR.0000000000001381","article-title":"Possible interaction between the ventral hippocampal cannabinoid CB2 and muscarinic acetylcholine receptors on the modulation of memory consolidation in mice","volume":"31","author":"Nasehi","year":"2020","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib402","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.phrs.2007.06.002","article-title":"Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations","volume":"56","author":"Mul\u00e8","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105729_bib403","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2018.06.006","article-title":"A cannabinoid receptor 2 agonist reduces blood-brain barrier damage via induction of MKP-1 after intracerebral hemorrhage in rats","volume":"1697","author":"Li","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2021.105729_bib404","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2010675","article-title":"Signaling mechanisms of selective PPAR\u03b3 modulators in Alzheimer\u2019s disease","volume":"2018","author":"Govindarajulu","year":"2018","journal-title":"PPAR Res."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib405","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ajpath.2012.11.024","article-title":"Activation of cannabinoid CB2 receptor-mediated AMPK\/CREB pathway reduces cerebral ischemic injury","volume":"182","author":"Choi","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib406","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2006.10.053","article-title":"Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain","volume":"412","author":"Ashton","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"A","key":"10.1016\/j.phrs.2021.105729_bib407","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuropharm.2016.03.015","article-title":"Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer\u2019s disease","volume":"110","author":"K\u00f6falvi","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib408","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1038\/s41598-019-43858-4","article-title":"CB2 receptor deletion on myeloid cells enhanced mechanical allodynia in a mouse model of neuropathic pain","volume":"9","author":"Nent","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib409","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1471-4892(02)00004-8","article-title":"CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?","volume":"3","author":"Malan","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib410","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/molecules25030453","article-title":"Microglial phenotypes and their relationship to the cannabinoid system: therapeutic implications for Parkinson\u2019s disease","volume":"25","author":"Kelly","year":"2020","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib411","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1523\/JNEUROSCI.3923-04.2005","article-title":"A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis","volume":"25","author":"Benito","year":"2005","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"35","key":"10.1016\/j.phrs.2021.105729_bib412","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer\u2019s disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib413","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ram\u00edrez","year":"2005","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.phrs.2021.105729_bib414","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2017.05.044","article-title":"Activation of CB(2) receptor system restores cognitive capacity and hippocampal Sox2 expression in a transgenic mouse model of Alzheimer\u2019s disease","volume":"811","author":"Wu","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib415","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1111\/ejn.13414","article-title":"Activation of cannabinoid receptor 2 attenuates mechanical allodynia and neuroinflammatory responses in a chronic post-ischemic pain model of complex regional pain syndrome type I in rats","volume":"44","author":"Xu","year":"2016","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib416","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.anes.0000264765.33673.6c","article-title":"Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision","volume":"106","author":"Romero-Sandoval","year":"2007","journal-title":"Anesthesiology"},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib417","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1111\/j.1476-5381.2012.01948.x","article-title":"Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells","volume":"166","author":"Merighi","year":"2012","journal-title":"Br. J. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib418","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/glia.10177","article-title":"Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide","volume":"41","author":"Facchinetti","year":"2003","journal-title":"Glia"},{"issue":"112","key":"10.1016\/j.phrs.2021.105729_bib419","first-page":"112","article-title":"Inflammatory regulation by driving microglial M2 polarization: neuroprotective effects of cannabinoid receptor-2 activation in intracerebral hemorrhage","volume":"8","author":"Lin","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2021.105729_bib420","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2008.07.037","article-title":"Endocannabinoid signaling in microglial cells","volume":"56","author":"Stella","year":"2009","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib421","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1073\/pnas.0306707101","article-title":"P2X7 receptors control 2-arachidonoylglycerol production by microglial cells","volume":"101","author":"Witting","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.phrs.2021.105729_bib422","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1523\/JNEUROSCI.4830-06.2007","article-title":"Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells","volume":"27","author":"Muccioli","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib423","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2007.05.015","article-title":"Microglia produce and hydrolyze palmitoylethanolamide","volume":"54","author":"Muccioli","year":"2008","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib424","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer\u2019s disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib425","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbrc.2015.01.073","article-title":"Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling","volume":"458","author":"Ma","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib426","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.3390\/ph3082517","article-title":"Brain CB\u2082 receptors: implications for neuropsychiatric disorders","volume":"3","author":"Roche","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.phrs.2021.105729_bib427","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","article-title":"Endocannabinoids drive the acquisition of an alternative phenotype in microglia","volume":"49","author":"Mecha","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2021.105729_bib428","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fncel.2019.00424","article-title":"The endocannabinoid system as a window into microglial biology and its relationship to autism","volume":"13","author":"Araujo","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"87","key":"10.1016\/j.phrs.2021.105729_bib429","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fneur.2020.00087","article-title":"Endocannabinoid modulation of microglial phenotypes in neuropathology","volume":"11","author":"Tanaka","year":"2020","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib430","doi-asserted-by":"crossref","first-page":"23493","DOI":"10.1371\/journal.pone.0023493","article-title":"ERK\/MAPK is essential for endogenous neuroprotection in SCN2.2 cells","volume":"6","author":"Karmarkar","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib431","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jnr.20422","article-title":"N-methyl-D-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathway","volume":"80","author":"Zhu","year":"2005","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib432","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jcb.21013","article-title":"ERK 1\/2 signaling pathway is involved in nicotine-mediated neuroprotection in spinal cord neurons","volume":"100","author":"Toborek","year":"2007","journal-title":"J. Cell. Biochem."},{"issue":"13","key":"10.1016\/j.phrs.2021.105729_bib433","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1523\/JNEUROSCI.0550-09.2009","article-title":"17\u03b2-Estradiol-mediated Neuroprotection and ERK Activation Require A Pertussis Toxin-sensitive Mechanism Involving GRK2 and \u03b2-Arrestin-1","volume":"29","author":"Dominguez","year":"2009","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib434","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","article-title":"The role of PI3K\/Akt and ERK in neurodegenerative disorders","volume":"35","author":"Rai","year":"2019","journal-title":"Neurotox. Res."},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib435","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri3495","article-title":"Mitogen-activated protein kinases in innate immunity","volume":"13","author":"Arthur","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2021.105729_bib436","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3389\/fphar.2018.00462","article-title":"The anti-neuroinflammatory activity of tectorigenin pretreatment via downregulated NF-\u03baB and ERK\/JNK pathways in BV-2 microglial and microglia inactivation in mice with lipopolysaccharide","volume":"9","author":"Lim","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib437","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2174\/1567202616666181123152601","article-title":"ERK\/MAP kinase activation is evident in activated microglia of the striatum and substantia nigra in an acute and chronically-induced mouse model of Parkinson\u2019s disease","volume":"15","author":"Sarkar","year":"2019","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.phrs.2021.105729_bib438","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.redox.2017.09.017","article-title":"Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway","volume":"14","author":"Hou","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2021.105729_bib439","doi-asserted-by":"crossref","unstructured":"M.J. Chen, S. Ramesha, L.D. Weinstock, T. Gao, L. Ping, H. Xiao, E.B. Dammer, D.D. Duong, A.I. Levey, J.J. Lah, N.T. Seyfried, L.B. Wood, S. Rangaraju, Microglial ERK activation is a critical regulator of pro-inflammatory immune responses in Alzheimer\u2019s disease. bioRxiv. 2019:798215.","DOI":"10.1101\/798215"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib440","doi-asserted-by":"crossref","first-page":"163","DOI":"10.14348\/molcells.2017.0011","article-title":"Signaling pathways controlling microglia chemotaxis","volume":"40","author":"Fan","year":"2017","journal-title":"Mol. Cells"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib441","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11064-019-02922-1","article-title":"Dexmedetomidine inhibits neuroinflammation by altering microglial M1\/M2 polarization through MAPK\/ERK pathway","volume":"45","author":"Qiu","year":"2020","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib442","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jtcvs.2006.11.038","article-title":"Inhibition of the MEK\/ERK pathway reduces microglial activation and interleukin-1-beta expression in spinal cord ischemia\/reperfusion injury in rats","volume":"133","author":"Lu","year":"2007","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib443","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/biom10010137","article-title":"Microglia mediated neuroinflammation: focus on PI3K modulation","volume":"10","author":"Cianciulli","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib444","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1742-2094-9-111","article-title":"Heterotrimeric G protein-dependent WNT-5A signaling to ERK1\/2 mediates distinct aspects of microglia proinflammatory transformation","volume":"9","author":"Halleskog","year":"2012","journal-title":"J. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib445","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.cellsig.2012.12.006","article-title":"Pertussis toxin-sensitive heterotrimeric G(\u03b1i\/o) proteins mediate WNT\/\u03b2-catenin and WNT\/ERK1\/2 signaling in mouse primary microglia stimulated with purified WNT-3A","volume":"25","author":"Halleskog","year":"2013","journal-title":"Cell Signal."},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib446","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/2211-5463.12270","article-title":"G protein-coupled \u03b17 nicotinic receptor regulates signaling and TNF-\u03b1 release in microglia","volume":"7","author":"King","year":"2017","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.phrs.2021.105729_bib447","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/308461","article-title":"The interplay between cyclic AMP, MAPK, and NF-\u03baB pathways in response to proinflammatory signals in microglia","volume":"2015","author":"Ghosh","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib448","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/glia.22401","article-title":"Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microgliain vitroand following CNS injury","volume":"60","author":"Ghosh","year":"2012","journal-title":"Glia"},{"issue":"23","key":"10.1016\/j.phrs.2021.105729_bib449","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1007\/s00018-011-0757-8","article-title":"Cyclic AMP: a selective modulator of NF-\u03baB action","volume":"68","author":"Gerlo","year":"2011","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"key":"10.1016\/j.phrs.2021.105729_bib450","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fnins.2016.00449","article-title":"Mild traumatic brain injury produces neuron loss that can be rescued by modulating microglial activation using a CB2 receptor inverse agonist","volume":"10","author":"Bu","year":"2016","journal-title":"Front. Neurosci."},{"issue":"24","key":"10.1016\/j.phrs.2021.105729_bib451","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1007\/s00018-019-03152-y","article-title":"Regulation of AMPK activity by type 10 adenylyl cyclase: contribution to the mitochondrial biology, cellular redox and energy homeostasis","volume":"76","author":"Jayarajan","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib452","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.cellsig.2009.01.015","article-title":"Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, epac and lipolysis","volume":"21","author":"Omar","year":"2009","journal-title":"Cell Signal."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib453","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/eji.200425524","article-title":"Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors","volume":"35","author":"Minguet","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2021.105729_bib454","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.1001829","article-title":"The role of the transcription factor CREB in immune function","volume":"185","author":"Wen","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib455","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/CCM.0000000000000882","article-title":"Posttraumatic stress disorder in critical illness survivors: a metaanalysis","volume":"43","author":"Parker","year":"2015","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib456","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11064-016-2123-6","article-title":"Anti-Neuroinflammatory Effects Of Fucoxanthin Via Inhibition Of Akt\/NF-\u03baB and MAPKs\/AP-1 Pathways And Activation of PKA\/CREB Pathway In Lipopolysaccharide-activated BV-2 Microglial Cells","volume":"42","author":"Zhao","year":"2017","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib457","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/glia.22762","article-title":"Redox regulation of NF-kappaB p50 and M1 polarization in microglia","volume":"63","author":"Taetzsch","year":"2015","journal-title":"Glia"},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib458","doi-asserted-by":"crossref","first-page":"11363","DOI":"10.1021\/acsami.9b23004","article-title":"Modulation of Microglia Polarization Through Silencing of NF-\u03baB p65 by Functionalized Curdlan Nanoparticle-mediated RNAi","volume":"12","author":"Ganbold","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"37","key":"10.1016\/j.phrs.2021.105729_bib459","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fnsys.2019.00037","article-title":"Different Approaches To Modulation Of Microglia Phenotypes After Spinal Cord Injury","volume":"13","author":"Akhmetzyanova","year":"2019","journal-title":"Front. Syst. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib460","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bbadis.2014.12.019","article-title":"Treatment in vitro with PPAR\u03b1 and PPAR\u03b3 ligands drives M1-to-M2 polarization of macrophages from T. cruzi-infected mice","volume":"1852","author":"Penas","year":"2015","journal-title":"Biochim. Et. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib461","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12974-020-01940-z","article-title":"Immunoregulation of microglial polarization: an unrecognized physiological function of \u03b1-synuclein","volume":"17","author":"Li","year":"2020","journal-title":"J. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib462","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1159\/000491059","article-title":"Schisantherin A attenuates neuroinflammation in activated microglia: role of Nrf2 activation through ERK phosphorylation","volume":"47","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib463","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1007\/s12035-018-0975-2","article-title":"Activation of Nrf2 pathway contributes to neuroprotection by the dietary flavonoid tiliroside","volume":"55","author":"Velagapudi","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"46","key":"10.1016\/j.phrs.2021.105729_bib464","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc1428","article-title":"Therapeutics potentiating microglial p21-Nrf2 axis can rescue neurodegeneration caused by neuroinflammation","volume":"6","author":"Nakano-Kobayashi","year":"2020","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib465","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/intimm\/dxh072","article-title":"Up-regulation of IL-4 production by the activated cAMP\/cAMP-dependent protein kinase (protein kinase A) pathway in CD3\/CD28-stimulated naive T cells","volume":"16","author":"Tokoyoda","year":"2004","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib466","doi-asserted-by":"crossref","first-page":"16931","DOI":"10.1038\/s41598-018-35184-y","article-title":"Unique, intersecting, and overlapping roles of C\/EBP \u03b2 and CREB in cells of the innate immune system","volume":"8","author":"Larabee","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2021.105729_bib467","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2017.12.005","article-title":"Both classic Gs-cAMP\/PKA\/CREB and alternative Gs-cAMP\/PKA\/p38\u03b2\/CREB signal pathways mediate exenatide-stimulated expression of M2 microglial markers","volume":"316","author":"Wu","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib468","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41419-018-0288-4","article-title":"Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis","volume":"9","author":"Rossi","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib469","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12974-016-0763-8","article-title":"Balancing the immune response in the brain: IL-10 and its regulation","volume":"13","author":"Lobo-Silva","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2021.105729_bib470","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: the good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2021.105729_bib471","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuroscience.2020.03.008","article-title":"IL-4 switches microglia\/macrophage M1\/M2 polarization and alleviates neurological damage by modulating the JAK1\/STAT6 pathway following ICH","volume":"437","author":"He","year":"2020","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib472","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1210\/en.2017-00163","article-title":"How protein kinase A activates canonical tyrosine kinase signaling pathways to promote granulosa cell differentiation","volume":"158","author":"Law","year":"2017","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib473","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0197-0186(03)00150-5","article-title":"A cAMP-activated pathway, including PKA and PI3K, regulates neuronal differentiation","volume":"44","author":"S\u00e1nchez","year":"2004","journal-title":"Neurochem. Int."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib474","first-page":"2006","article-title":"Modulators of microglia activation and polarization in ischemic stroke (Review)","volume":"21","author":"Jiang","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib475","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/glia.23484","article-title":"How to reprogram microglia toward beneficial functions","volume":"66","author":"Fumagalli","year":"2018","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib476","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/mp.2017.167","article-title":"DHEA inhibits acute microglia-mediated inflammation through activation of the TrkA-Akt1\/2-CREB-Jmjd3 pathway","volume":"23","author":"Alexaki","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib477","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12974-020-01887-1","article-title":"BDNF reverses aging-related microglial activation","volume":"17","author":"Wu","year":"2020","journal-title":"J. Neuroinflamm."},{"issue":"442","key":"10.1016\/j.phrs.2021.105729_bib478","article-title":"Loss of microglia and impaired brain-neurotrophic factor signaling pathway in a comorbid model of chronic pain and depression","volume":"9","author":"Zhu","year":"2018","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib479","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1021\/acschemneuro.8b00713","article-title":"Neuroprotective effects of BHDPC, a novel neuroprotectant, on experimental stroke by modulating microglia polarization","volume":"10","author":"Li","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib480","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11010-017-3064-3","article-title":"AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia","volume":"435","author":"Velagapudi","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.phrs.2021.105729_bib481","article-title":"Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation","volume":"2014","author":"Chen","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.phrs.2021.105729_bib482","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijdevneu.2019.01.007","article-title":"Involvement of AMP-activated protein kinase in neuroinflammation and neurodegeneration in the adult and developing brain","volume":"77","author":"Saito","year":"2019","journal-title":"Int. J. Dev. Neurosci.: Off. J. Int. Soc. Dev. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib483","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12031-015-0500-2","article-title":"AMPK plays a dual role in regulation of CREB\/BDNF pathway in mouse primary hippocampal cells","volume":"56","author":"Huang","year":"2015","journal-title":"J. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib484","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070760","article-title":"Neurological enhancement effects of melatonin against brain injury-induced oxidative stress, neuroinflammation, and neurodegeneration via AMPK\/CREB signaling","volume":"8","author":"Rehman","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib485","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/cells8030250","article-title":"Increased levels of cAMP by the calcium-dependent activation of soluble adenylyl cyclase in parkin-mutant fibroblasts","volume":"8","author":"Tanzarella","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib486","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.cmet.2013.05.003","article-title":"Mitochondrial Ca2+ uptake induces cyclic AMP generation in the matrix and modulates organelle ATP levels","volume":"17","author":"Di Benedetto","year":"2013","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib487","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.bpj.2019.10.003","article-title":"Computational modeling reveals frequency modulation of calcium-cAMP\/PKA pathway in dendritic spines","volume":"117","author":"Ohadi","year":"2019","journal-title":"Biophys. J."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib488","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1152\/physrev.00049.2006","article-title":"Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains","volume":"87","author":"Willoughby","year":"2007","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib489","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000166277","article-title":"Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies","volume":"17","author":"Sadana","year":"2009","journal-title":"Neurosignals"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib490","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004143","article-title":"Regulation by Ca2+-signaling pathways of adenylyl cyclases","volume":"3","author":"Halls","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib491","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tibs.2005.11.009","article-title":"Chutes and Ladders: the search for protein kinases that act on AMPK","volume":"31","author":"Witters","year":"2006","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib492","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5607\/en.2012.21.2.52","article-title":"AMP-activated protein kinase (AMPK) and energy-sensing in the brain","volume":"21","author":"Ramamurthy","year":"2012","journal-title":"Exp. Neurobiol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib493","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bja\/aeu268","article-title":"Sevoflurane post-conditioning increases nuclear factor erythroid 2-related factor and haemoxygenase-1 expression via protein kinase C pathway in a rat model of transient global cerebral ischaemia","volume":"114","author":"Lee","year":"2014","journal-title":"BJA: Br. J. Anaesth."},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib494","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/glia.20412","article-title":"Functional role of calcium signals for microglial function","volume":"54","author":"F\u00e4rber","year":"2006","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib495","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4161\/chan.3.2.8609","article-title":"The Ca2+ release-activated Ca2+ current (ICRAC) mediates store-operated Ca2+ entry in rat microglia","volume":"3","author":"Ohana","year":"2009","journal-title":"Channels"},{"issue":"11","key":"10.1016\/j.phrs.2021.105729_bib496","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1523\/JNEUROSCI.23-11-04410.2003","article-title":"Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function","volume":"23","author":"Hoffmann","year":"2003","journal-title":"J. Neurosci."},{"issue":"497","key":"10.1016\/j.phrs.2021.105729_bib497","article-title":"The role of ion channels in microglial activation and proliferation\u2009\u2013\u2009a complex interplay between ligand-gated ion channels, K+ channels, and intracellular Ca2+","volume":"6","author":"Stebbing","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2021.105729_bib498","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fncel.2017.00069","article-title":"Microglial intracellular Ca2+ signaling in synaptic development and its alterations in neurodevelopmental disorders","volume":"11","author":"Mizoguchi","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib499","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.bbamcr.2010.10.018","article-title":"Microglial calcium signal acts as a rapid sensor of single neuron damage in vivo","volume":"1813","author":"Eichhoff","year":"2011","journal-title":"Biochim. Et Biophys. Acta (BBA) - Mol. Cell Res."},{"issue":"11","key":"10.1016\/j.phrs.2021.105729_bib500","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.3390\/ijms18112366","article-title":"In vivo imaging of microglial calcium signaling in brain inflammation and injury","volume":"18","author":"Tvrdik","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib501","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/mol.113.087403","article-title":"Structural insights into phospholipase C-\u03b2 function","volume":"84","author":"Lyon","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105729_bib502","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-94-007-3012-0_3","article-title":"The phospholipase C isozymes and their regulation","volume":"58","author":"Gresset","year":"2012","journal-title":"Subcell. Biochem"},{"issue":"17","key":"10.1016\/j.phrs.2021.105729_bib503","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1074\/jbc.RA118.002354","article-title":"G protein \u03b2\u03b3 subunits directly interact with and activate phospholipase C\u03f5","volume":"293","author":"Madukwe","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2021.105729_bib504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jbior.2014.09.014","article-title":"PLC\u03b5 mediated sustained signaling pathways","volume":"57","author":"Dusaban","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.phrs.2021.105729_bib505","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-physiol-030212-183750","article-title":"Mammalian phospholipase C","volume":"75","author":"Kadamur","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.phrs.2021.105729_bib506","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ceca.2018.07.003","article-title":"STIM- and orai-mediated calcium entry controls NF-\u03baB activity and function in lymphocytes","volume":"74","author":"Berry","year":"2018","journal-title":"Cell Calcium"},{"issue":"8","key":"10.1016\/j.phrs.2021.105729_bib507","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.4049\/jimmunol.1602033","article-title":"Integration of kinase and calcium signaling at the level of chromatin underlies inducible gene activation in T cells","volume":"199","author":"Brignall","year":"2017","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib508","first-page":"150","article-title":"The role of calcium, NF-\u03baB and NFAT in the regulation of CXCL8 and IL-6 expression in Jurkat T-cells","volume":"4","author":"Khalaf","year":"2013","journal-title":"Int. J. Biochem Mol. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib509","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1038\/s41598-017-05952-3","article-title":"A new approach for ratiometric in vivo calcium imaging of microglia","volume":"7","author":"Brawek","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2021.105729_bib510","doi-asserted-by":"crossref","unstructured":"B. Chun, B.D. Stewart, D. Vaughan, A.D. Bachstetter, P.M. Kekenes-Huskey, Simulation of P2X-mediated calcium signaling in microglia. bioRxiv. 2018:354142.","DOI":"10.1101\/354142"},{"key":"10.1016\/j.phrs.2021.105729_bib511","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56502","article-title":"Microglial calcium signaling is attuned to neuronal activity in awake mice","volume":"9","author":"Umpierre","year":"2020","journal-title":"eLife"},{"issue":"321","key":"10.1016\/j.phrs.2021.105729_bib512","first-page":"321","article-title":"Cannabinoid type 2 (CB2) receptors activation protects against oxidative stress and neuroinflammation associated dopaminergic neurodegeneration in rotenone model of Parkinson\u2019s disease","volume":"10","author":"Javed","year":"2016","journal-title":"Front. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib513","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.chembiol.2015.04.013","article-title":"Sulfenylation regulates 2-AG-mediated endocannabinoid signaling in brain neurons","volume":"22","author":"Dotsey","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.phrs.2021.105729_bib514","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2017.02.033","article-title":"Monoglyceride lipase as a drug target: at the crossroads of arachidonic acid metabolism and endocannabinoid signaling","volume":"175","author":"Grabner","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib515","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ams2.443","article-title":"A case series of the dynamics of lipid mediators in patients with sepsis","volume":"6","author":"Hamaguchi","year":"2019","journal-title":"Acute Med. Surg."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib516","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0968051907078607","article-title":"The mRNA expression of fatty acid amide hydrolase in human whole blood correlates with sepsis","volume":"13","author":"Tanaka","year":"2007","journal-title":"J. Endotoxin Res."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib517","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/abbi.2001.2500","article-title":"Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes","volume":"393","author":"Maccarrone","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib518","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000258710","article-title":"Inflammatory agents involved in septic miscarriage","volume":"17","author":"Aisemberg","year":"2010","journal-title":"Neuroimmunomodulation"},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib519","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/jcp.25640","article-title":"Peripheral blood mononuclear cells infiltration downregulates decidual FAAH activity in an LPS-induced embryo resorption model","volume":"232","author":"Wolfson","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"16","key":"10.1016\/j.phrs.2021.105729_bib520","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1073\/pnas.0510418103","article-title":"Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection","volume":"103","author":"Witting","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.phrs.2021.105729_bib521","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/glia.22380","article-title":"Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation","volume":"60","author":"Krishnan","year":"2012","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib522","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/glia.20229","article-title":"Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures","volume":"52","author":"Ortega-Guti\u00e9rrez","year":"2005","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib523","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/glia.20907","article-title":"Anandamide enhances IL-10 production in activated microglia by targeting CB2receptors: roles of ERK1\/2, JNK, and NF-\u03baB","volume":"58","author":"Correa","year":"2009","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib524","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/BJ20071329","article-title":"Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E2","volume":"409","author":"Correa","year":"2008","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib525","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2567.2008.02838.x","article-title":"Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats","volume":"125","author":"Roche","year":"2008","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib526","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jneuroim.2010.02.006","article-title":"The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-alpha induced by lipopolysaccharide","volume":"221","author":"De Laurentiis","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib527","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1113\/jphysiol.2010.202465","article-title":"The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors","volume":"589","author":"Steiner","year":"2011","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib528","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.imbio.2011.07.028","article-title":"Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome","volume":"217","author":"Kerr","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.phrs.2021.105729_bib529","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbi.2017.02.016","article-title":"Pharmacological inhibition of FAAH modulates TLR-induced neuroinflammation, but not sickness behaviour: an effect partially mediated by central TRPV1","volume":"62","author":"Henry","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib530","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12035-007-8008-6","article-title":"Endocannabinoids and traumatic brain injury","volume":"36","author":"Mechoulam","year":"2007","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib531","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.jcbfm.9600047","article-title":"CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition","volume":"25","author":"Panikashvili","year":"2005","journal-title":"J. Cereb. Blood Flow. Metab.: Off. J. Int. Soc. Cereb. Blood Flow. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib532","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nbd.2005.11.004","article-title":"The endocannabinoid 2-AG protects the blood\u2013brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines","volume":"22","author":"Panikashvili","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib533","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1124\/mol.63.2.429","article-title":"Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway","volume":"63","author":"Sancho","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib534","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/0333102415613766","article-title":"The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat","volume":"36","author":"Nagy-Gr\u00f3cz","year":"2016","journal-title":"Cephalalgia: Int. J. Headache"},{"issue":"16","key":"10.1016\/j.phrs.2021.105729_bib535","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.febslet.2007.05.037","article-title":"Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators","volume":"581","author":"Tham","year":"2007","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib536","doi-asserted-by":"crossref","first-page":"60040","DOI":"10.1371\/journal.pone.0060040","article-title":"Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism","volume":"8","author":"Starowicz","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.phrs.2021.105729_bib537","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/sj.bjp.0707145","article-title":"Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors","volume":"150","author":"Maione","year":"2007","journal-title":"Br. J. Pharm."},{"issue":"7","key":"10.1016\/j.phrs.2021.105729_bib538","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/glia.23317","article-title":"2-AG limits Theiler\u2019s virus induced acute neuroinflammation by modulating microglia and promoting MDSCs","volume":"66","author":"Mecha","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2021.105729_bib539","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2018.12.013","article-title":"The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia","volume":"77","author":"Mecha","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib540","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1177\/0271678X20951995","article-title":"Regulation of blood\u2013brain barrier integrity by microglia in health and disease: a therapeutic opportunity","volume":"40","author":"Ronaldson","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib541","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-014-0201-8","article-title":"T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases","volume":"11","author":"Gonz\u00e1lez","year":"2014","journal-title":"J. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib542","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1471-4159.2005.03380.x","article-title":"Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli","volume":"95","author":"Maresz","year":"2005","journal-title":"J. Neurochem."},{"issue":"46","key":"10.1016\/j.phrs.2021.105729_bib543","doi-asserted-by":"crossref","first-page":"12136","DOI":"10.1523\/JNEUROSCI.3402-08.2008","article-title":"Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain","volume":"28","author":"Racz","year":"2008","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib544","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1460-9568.2008.06377.x","article-title":"Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide","volume":"28","author":"Lor\u00eda","year":"2008","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib545","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jnr.22721","article-title":"Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist","volume":"90","author":"Lou","year":"2012","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib546","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/apha.12474","article-title":"Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells","volume":"214","author":"Jean-Gilles","year":"2015","journal-title":"Acta Physiol."},{"key":"10.1016\/j.phrs.2021.105729_bib547","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.freeradbiomed.2014.03.015","article-title":"Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J. infection: role of NADPH oxidase","volume":"71","author":"Wang","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.phrs.2021.105729_bib548","doi-asserted-by":"crossref","DOI":"10.3390\/cells7100159","article-title":"Pathophysiological Alterations Of Redox Signaling And Endocannabinoid System In Granulocytes And Plasma Of Psoriatic Patients","volume":"7","author":"Ambro\u017cewicz","year":"2018","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib549","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10571-019-00719-y","article-title":"Cannabinoid CB(2) Receptor Modulation By The Transcription Factor NRF2 is Specific In Microglial Cells","volume":"40","author":"Gal\u00e1n-Ganga","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.phrs.2021.105729_bib550","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.3390\/ijms21124448","article-title":"Cannabis, the endocannabinoid System and Immunity-the journey from the Bedside To The Bench And Back","volume":"21","author":"Almogi-Hazan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib551","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11481-013-9485-1","article-title":"Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction","volume":"8","author":"Robinson","year":"2013","journal-title":"J. NeuroImmune Pharmacol.: Off. J. Soc. NeuroImmune Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105729_bib552","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/ATVBAHA.116.307344","article-title":"Inhibition of orai1 Store-operated calcium channel prevents foam cell formation and atherosclerosis","volume":"36","author":"Liang","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2021.105729_bib553","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.isci.2018.09.014","article-title":"M1 macrophage Polarization Is Dependent on TRPC1-Mediated Calcium Entry","volume":"8","author":"Chauhan","year":"2018","journal-title":"iScience"},{"issue":"19","key":"10.1016\/j.phrs.2021.105729_bib554","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1073\/pnas.1612177114","article-title":"Endocannabinoid system acts as a regulator of immune homeostasis in the gut","volume":"114","author":"Acharya","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib555","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phrs.2009.03.019","article-title":"Endocannabinoids and immune regulation","volume":"60","author":"Pandey","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105729_bib556","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12916-014-0259-2","article-title":"Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses","volume":"13","author":"Morris","year":"2015","journal-title":"BMC Med."},{"issue":"17\u201318","key":"10.1016\/j.phrs.2021.105729_bib557","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.lfs.2007.08.042","article-title":"Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts","volume":"81","author":"L\u00e9picier","year":"2007","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib558","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00414-010-0465-1","article-title":"The cannabinoid receptor type 2 is time-dependently expressed during skeletal muscle wound healing in rats","volume":"124","author":"Yu","year":"2010","journal-title":"Int. J. Leg. Med."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib559","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00418-005-0127-4","article-title":"Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes","volume":"126","author":"Roche","year":"2006","journal-title":"Histochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib560","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.bjp.0707486","article-title":"Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation","volume":"153","author":"Wright","year":"2008","journal-title":"Br. J. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib561","doi-asserted-by":"crossref","first-page":"G181","DOI":"10.1152\/ajpgi.00133.2012","article-title":"Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms","volume":"304","author":"Michler","year":"2013","journal-title":"Am. J. Physiol. -Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phrs.2021.105729_bib562","article-title":"CB2 receptor activation ameliorates the proinflammatory activity in acute lung injury induced by paraquat","volume":"2014","author":"Liu","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib563","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1152\/physiolgenomics.00001.2019","article-title":"Activation of the cannabinoid receptor 2 increases renal perfusion","volume":"51","author":"Pressly","year":"2019","journal-title":"Physiol. Genom."},{"issue":"2","key":"10.1016\/j.phrs.2021.105729_bib564","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/sj.bjp.0707511","article-title":"CB2 receptors as new therapeutic targets for liver diseases","volume":"153","author":"Lotersztajn","year":"2008","journal-title":"Br. J. Pharm."},{"issue":"5","key":"10.1016\/j.phrs.2021.105729_bib565","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1159\/000453171","article-title":"Cannabinoid 2 receptor agonist improves systemic sensitivity to insulin in high-fat diet\/streptozotocin-induced diabetic mice","volume":"40","author":"Zhang","year":"2016","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib566","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.2337\/db10-1809","article-title":"Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy","volume":"60","author":"Barutta","year":"2011","journal-title":"Diabetes"},{"issue":"35","key":"10.1016\/j.phrs.2021.105729_bib567","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.2174\/0929867321666140915141332","article-title":"Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases","volume":"21","author":"Carbone","year":"2014","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib568","doi-asserted-by":"crossref","first-page":"129","DOI":"10.15171\/jcvtr.2018.21","article-title":"New insights on atherosclerosis: a cross-talk between endocannabinoid systems with gut microbiota","volume":"10","author":"Moludi","year":"2018","journal-title":"J. Cardiovasc. Thorac. Res."},{"issue":"9","key":"10.1016\/j.phrs.2021.105729_bib569","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.3390\/ijms19092690","article-title":"Role of cannabinoids in obesity","volume":"19","author":"Rossi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3\u20134","key":"10.1016\/j.phrs.2021.105729_bib570","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.lfs.2010.05.008","article-title":"Effect of simvastatin on Kruppel-like factor2, endothelial nitric oxide synthase and thrombomodulin expression in endothelial cells under shear stress","volume":"87","author":"Rossi","year":"2010","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib571","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2018.12.011","article-title":"Crystal structure of the human cannabinoid receptor CB2","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib572","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1517\/14728210902736568","article-title":"Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis","volume":"14","author":"Janero","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"1","key":"10.1016\/j.phrs.2021.105729_bib573","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1467-789X.2008.00520.x","article-title":"A critical review of the cannabinoid receptor as a drug target for obesity management","volume":"10","author":"Akbas","year":"2009","journal-title":"Obes. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2021.105729_bib574","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/0269881114565142","article-title":"The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects","volume":"29","author":"van Amsterdam","year":"2015","journal-title":"J. Psychopharmacol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821003133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821003133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:31:45Z","timestamp":1760913105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821003133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":574,"alternative-id":["S1043661821003133"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105729","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The endocannabinoidome in neuropsychiatry: Opportunities and potential risks","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105729"}}